<body><document>
<type>N-Q
<sequence>1
<filename>filing758.htm
<description>PRIMARY DOCUMENT
<text>


 <div style="WIDTH:576px"> <p style="FONT-SIZE:12pt; MARGIN:0px" align="center">UNITED STATES</p> <p style="FONT-SIZE:12pt; MARGIN:0px" align="center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="FONT-SIZE:12pt; MARGIN:0px" align="center">Washington, D.C. 20549</p> <p style="MARGIN:0px" align="center"><br/></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align="center"><b>FORM N-Q</b></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align="center"><b>QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY</b></p> <p style="MARGIN:0px" align="center"><br/></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align="center">Investment Company Act file number &#160;&#160;<u>811-3010</u></p> <p style="MARGIN:0px" align="center"><br/></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align="center"><u>Fidelity Advisor Series VII</u> </p> <p style="FONT-SIZE:12pt; MARGIN:0px" align="center">(Exact name of registrant as specified in charter)</p> <p style="MARGIN:0px" align="center"><br/></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align="center"><u>245 Summer St., Boston, Massachusetts &#160;02210</u> </p> <p style="FONT-SIZE:12pt; MARGIN:0px" align="center">(Address of principal executive offices) &#160; &#160; &#160; (Zip code)</p> <p style="MARGIN:0px" align="center"><br/></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align="center">Marc Bryant, Secretary</p> <p style="FONT-SIZE:12pt; MARGIN:0px" align="center">245 Summer St.</p> <p style="FONT-SIZE:12pt; MARGIN:0px" align="center"><u>Boston, Massachusetts &#160;02210</u></p> <p style="FONT-SIZE:12pt; MARGIN:0px" align="center">(Name and address of agent for service)</p> <p style="MARGIN:0px" align="center"><br/></p> <p style="MARGIN:0px"><br/></p> <p style="MARGIN-BOTTOM:-2px; FONT-SIZE:12pt; WIDTH:336px; FLOAT:left; MARGIN-TOP:0px">Registrant's telephone number, including area code:</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px"><u>617-563-7000</u></p> <p style="CLEAR:left; MARGIN:0px"><br/></p> <p style="MARGIN:0px"><br/></p> <table style="FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding="0" cellspacing="0"> <tr style="FONT-SIZE:0px"> <td width="187"> </td><td width="264"/> </tr><tr> <td width="187" height="19" style="MARGIN-TOP:0px" valign="top"> <p style="FONT-SIZE:12pt; MARGIN:0px">Date of fiscal year end:</p></td> <td width="264" height="19" style="MARGIN-TOP:0px" valign="top"> <p style="FONT-SIZE:12pt; MARGIN:0px">July 31</p></td></tr> <tr> <td width="187" height="19" style="MARGIN-TOP:0px" valign="top"> <p style="MARGIN:0px"><br/></p></td> <td width="264" height="19" style="MARGIN-TOP:0px" valign="top"> <p style="MARGIN:0px"><br/></p></td></tr> <tr> <td width="187" height="19" style="MARGIN-TOP:0px" valign="top"> <p style="FONT-SIZE:12pt; MARGIN:0px">Date of reporting period:</p></td> <td width="264" height="19" style="MARGIN-TOP:0px" valign="top"> <p style="FONT-SIZE:12pt; MARGIN:0px">October 31, 2017</p></td></tr></table> <p style="MARGIN:0px"><br/></p> <p style="MARGIN-BOTTOM:-2px; FONT-SIZE:12pt; WIDTH:96px; FLOAT:left; MARGIN-TOP:0px">Item 1.</p> <p style="FONT-SIZE:12pt; MARGIN:0px; TEXT-INDENT:-2px"><u>Schedule of Investments</u></p> <p style="CLEAR:left; MARGIN:0px"><br/></p> <p style="MARGIN:0px"><br/><br/></p></div>
<div style="font: normal 11pt Arial, Helvetica, sans-serif; width: 780px">
<!-- Automatically produced using the ProofPlus Content Management System -->
<p style="font: bold 18pt Arial, Helvetica, sans-serif; margin-bottom: 0px;" align="center">Quarterly Holdings Report<br clear="all"/>for</p>
<p style="font: bold 20pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">Fidelity Advisor&#174; Biotechnology Fund</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">October 31, 2017</p>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>AFBT-QTLY-1217<br/>1.809084.114<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<a name="">
<p style="font: bold 16pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investments October 31, 2017 (Unaudited)</p>
</a>
<p style="font: normal 11pt Arial, Helvetica, sans-serif; margin-top: 0px;">Showing Percentage of Net Assets</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="0" cellpadding="5" width="745">
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Common Stocks - 97.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td/><td style="font-weight: bold;" align="center" valign="bottom">Shares&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Value&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Biotechnology - 88.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Biotechnology - 88.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">AbbVie, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">562,565&#160;</td><td align="right" valign="bottom">$50,771,491&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Abeona Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">33,454&#160;</td><td align="right" valign="bottom">600,499&#160;</td>
</tr>
<tr>
<td align="left" valign="top">AC Immune SA  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">281,288&#160;</td><td align="right" valign="bottom">3,307,947&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ACADIA Pharmaceuticals, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">468,186&#160;</td><td align="right" valign="bottom">16,306,918&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Acceleron Pharma, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">579,366&#160;</td><td align="right" valign="bottom">22,595,274&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Achaogen, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">431,602&#160;</td><td align="right" valign="bottom">5,489,977&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Achillion Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">278,861&#160;</td><td align="right" valign="bottom">1,121,021&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Acorda Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">311,253&#160;</td><td align="right" valign="bottom">8,271,548&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Adamas Pharmaceuticals, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">560,348&#160;</td><td align="right" valign="bottom">13,818,182&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Adaptimmune Therapeutics PLC sponsored ADR  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">844,942&#160;</td><td align="right" valign="bottom">6,632,795&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ADMA Biologics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">41,500&#160;</td><td align="right" valign="bottom">97,110&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Aduro Biotech, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">461,280&#160;</td><td align="right" valign="bottom">3,667,176&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Advaxis, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">138,328&#160;</td><td align="right" valign="bottom">470,315&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Adverum Biotechnologies, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">107,429&#160;</td><td align="right" valign="bottom">349,144&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Agenus, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">251,560&#160;</td><td align="right" valign="bottom">920,710&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Agenus, Inc. warrants 1/9/18 (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">452,000&#160;</td><td align="right" valign="bottom">5&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Agios Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">60,471&#160;</td><td align="right" valign="bottom">3,886,471&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Aimmune Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">404,902&#160;</td><td align="right" valign="bottom">11,770,501&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Akebia Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">177,377&#160;</td><td align="right" valign="bottom">3,219,393&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Alder Biopharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">403,913&#160;</td><td align="right" valign="bottom">4,544,021&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Aldeyra Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">534,859&#160;</td><td align="right" valign="bottom">3,369,612&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Alexion Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">917,776&#160;</td><td align="right" valign="bottom">109,821,076&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Alkermes PLC  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">338,303&#160;</td><td align="right" valign="bottom">16,495,654&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Alnylam Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">238,935&#160;</td><td align="right" valign="bottom">29,111,840&#160;</td>
</tr>
<tr>
<td align="left" valign="top">AMAG Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">200,677&#160;</td><td align="right" valign="bottom">3,150,629&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Amarin Corp. PLC ADR  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">338,294&#160;</td><td align="right" valign="bottom">1,150,200&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Amgen, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,211,680&#160;</td><td align="right" valign="bottom">212,310,564&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Amicus Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">892,770&#160;</td><td align="right" valign="bottom">12,713,045&#160;</td>
</tr>
<tr>
<td align="left" valign="top">AnaptysBio, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">110,093&#160;</td><td align="right" valign="bottom">7,269,441&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Applied Genetic Technologies Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">80,536&#160;</td><td align="right" valign="bottom">273,822&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Aptevo Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">38,827&#160;</td><td align="right" valign="bottom">110,851&#160;</td>
</tr>
<tr>
<td align="left" valign="top">AquaBounty Technologies, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,394&#160;</td><td align="right" valign="bottom">8,782&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ardelyx, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">722,501&#160;</td><td align="right" valign="bottom">3,865,380&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Arena Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">713,386&#160;</td><td align="right" valign="bottom">19,996,210&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Argenx SE ADR&#160;</td><td valign="top"/><td align="right" valign="bottom">163,500&#160;</td><td align="right" valign="bottom">3,747,420&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Array BioPharma, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">2,563,063&#160;</td><td align="right" valign="bottom">26,784,008&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ascendis Pharma A/S sponsored ADR  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">38,300&#160;</td><td align="right" valign="bottom">1,301,434&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Asterias Biotherapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">115,938&#160;</td><td align="right" valign="bottom">289,845&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Atara Biotherapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">405,885&#160;</td><td align="right" valign="bottom">5,763,567&#160;</td>
</tr>
<tr>
<td align="left" valign="top">aTyr Pharma, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">88,020&#160;</td><td align="right" valign="bottom">422,496&#160;</td>
</tr>
<tr>
<td align="left" valign="top">aTyr Pharma, Inc.  (a)(c)&#160;</td><td valign="top"/><td align="right" valign="bottom">55,238&#160;</td><td align="right" valign="bottom">265,142&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Audentes Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">232,000&#160;</td><td align="right" valign="bottom">6,168,880&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Axovant Sciences Ltd.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">289,646&#160;</td><td align="right" valign="bottom">1,517,745&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Bellicum Pharmaceuticals, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">716,125&#160;</td><td align="right" valign="bottom">6,745,898&#160;</td>
</tr>
<tr>
<td align="left" valign="top">BioCryst Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">821,923&#160;</td><td align="right" valign="bottom">3,698,654&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Biogen, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">499,562&#160;</td><td align="right" valign="bottom">155,693,493&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Biohaven Pharmaceutical Holding Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">283,800&#160;</td><td align="right" valign="bottom">8,531,028&#160;</td>
</tr>
<tr>
<td align="left" valign="top">BioMarin Pharmaceutical, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">634,590&#160;</td><td align="right" valign="bottom">52,093,493&#160;</td>
</tr>
<tr>
<td align="left" valign="top">BioTime, Inc. warrants 10/1/18 (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">2&#160;</td><td align="right" valign="bottom">0&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Bioverativ, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">253,844&#160;</td><td align="right" valign="bottom">14,342,186&#160;</td>
</tr>
<tr>
<td align="left" valign="top">bluebird bio, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">65,695&#160;</td><td align="right" valign="bottom">9,138,175&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Blueprint Medicines Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">616,461&#160;</td><td align="right" valign="bottom">40,945,340&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Calithera Biosciences, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">176,388&#160;</td><td align="right" valign="bottom">2,839,847&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cara Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">185,337&#160;</td><td align="right" valign="bottom">2,324,126&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Catalyst Pharmaceutical Partners, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">17,900&#160;</td><td align="right" valign="bottom">51,194&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Celgene Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,340,065&#160;</td><td align="right" valign="bottom">135,306,363&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Celldex Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,018,636&#160;</td><td align="right" valign="bottom">2,485,472&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Chiasma, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">337,192&#160;</td><td align="right" valign="bottom">708,103&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Chiasma, Inc. warrants (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">81,298&#160;</td><td align="right" valign="bottom">32,914&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Chimerix, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">387,202&#160;</td><td align="right" valign="bottom">1,905,034&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cidara Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">34,800&#160;</td><td align="right" valign="bottom">267,960&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cidara Therapeutics, Inc.  (a)(c)&#160;</td><td valign="top"/><td align="right" valign="bottom">223,967&#160;</td><td align="right" valign="bottom">1,724,546&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Clovis Oncology, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">275,358&#160;</td><td align="right" valign="bottom">20,753,732&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Corbus Pharmaceuticals Holdings, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">486,950&#160;</td><td align="right" valign="bottom">3,457,345&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Corvus Pharmaceuticals, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">274,564&#160;</td><td align="right" valign="bottom">3,728,579&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cytokinetics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">352,477&#160;</td><td align="right" valign="bottom">4,811,311&#160;</td>
</tr>
<tr>
<td align="left" valign="top">CytomX Therapeutics, Inc.  (a)(c)&#160;</td><td valign="top"/><td align="right" valign="bottom">64,961&#160;</td><td align="right" valign="bottom">1,299,220&#160;</td>
</tr>
<tr>
<td align="left" valign="top">DBV Technologies SA sponsored ADR  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">233,900&#160;</td><td align="right" valign="bottom">5,477,938&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Dicerna Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">129,106&#160;</td><td align="right" valign="bottom">695,881&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Dynavax Technologies Corp.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">545,519&#160;</td><td align="right" valign="bottom">12,001,418&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Eagle Pharmaceuticals, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">67,784&#160;</td><td align="right" valign="bottom">3,643,390&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Edge Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">9,681&#160;</td><td align="right" valign="bottom">105,136&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Editas Medicine, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">212,057&#160;</td><td align="right" valign="bottom">5,259,014&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Emergent BioSolutions, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">41,255&#160;</td><td align="right" valign="bottom">1,691,042&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Enanta Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">46,887&#160;</td><td align="right" valign="bottom">2,328,877&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Epizyme, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,354,550&#160;</td><td align="right" valign="bottom">22,620,985&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Esperion Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">280,016&#160;</td><td align="right" valign="bottom">12,807,932&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Exact Sciences Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">426,982&#160;</td><td align="right" valign="bottom">23,479,740&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Exelixis, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,167,049&#160;</td><td align="right" valign="bottom">28,931,145&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fate Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">234,604&#160;</td><td align="right" valign="bottom">1,119,061&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fibrocell Science, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">56,867&#160;</td><td align="right" valign="bottom">127,382&#160;</td>
</tr>
<tr>
<td align="left" valign="top">FibroGen, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">624,645&#160;</td><td align="right" valign="bottom">34,886,423&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Five Prime Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">119,400&#160;</td><td align="right" valign="bottom">5,356,284&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Foundation Medicine, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">10,368&#160;</td><td align="right" valign="bottom">466,560&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Galapagos Genomics NV sponsored ADR  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">192,629&#160;</td><td align="right" valign="bottom">18,777,475&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Genmab A/S  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">75,218&#160;</td><td align="right" valign="bottom">15,189,014&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Genomic Health, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">22,284&#160;</td><td align="right" valign="bottom">730,692&#160;</td>
</tr>
<tr>
<td align="left" valign="top">GenSight Biologics SA  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">105,964&#160;</td><td align="right" valign="bottom">635,676&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Geron Corp.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">4,760,774&#160;</td><td align="right" valign="bottom">10,711,742&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Gilead Sciences, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">337,739&#160;</td><td align="right" valign="bottom">25,316,915&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Global Blood Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">389,967&#160;</td><td align="right" valign="bottom">15,520,687&#160;</td>
</tr>
<tr>
<td align="left" valign="top">GlycoMimetics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">23,800&#160;</td><td align="right" valign="bottom">273,700&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Halozyme Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">988,831&#160;</td><td align="right" valign="bottom">17,531,974&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Heron Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">475,742&#160;</td><td align="right" valign="bottom">7,302,640&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Histogenics Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">597,234&#160;</td><td align="right" valign="bottom">1,260,164&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Idera Pharmaceuticals, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">691,800&#160;</td><td align="right" valign="bottom">1,079,208&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ignyta, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">134,472&#160;</td><td align="right" valign="bottom">2,070,869&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Immune Design Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">242,835&#160;</td><td align="right" valign="bottom">1,202,033&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ImmunoGen, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">2,029,138&#160;</td><td align="right" valign="bottom">11,769,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Immunomedics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,320,254&#160;</td><td align="right" valign="bottom">14,153,123&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Incyte Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">453,579&#160;</td><td align="right" valign="bottom">51,367,822&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Infinity Pharmaceuticals, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">794,775&#160;</td><td align="right" valign="bottom">1,851,826&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Insmed, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">24,900&#160;</td><td align="right" valign="bottom">672,549&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Insys Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">50,494&#160;</td><td align="right" valign="bottom">260,044&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Intellia Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">139,192&#160;</td><td align="right" valign="bottom">4,331,655&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Intercept Pharmaceuticals, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">158,460&#160;</td><td align="right" valign="bottom">9,765,890&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Intrexon Corp.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">38,808&#160;</td><td align="right" valign="bottom">634,511&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ionis Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">403,938&#160;</td><td align="right" valign="bottom">23,068,899&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Iovance Biotherapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">248,746&#160;</td><td align="right" valign="bottom">1,934,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ironwood Pharmaceuticals, Inc. Class A  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,110,821&#160;</td><td align="right" valign="bottom">17,084,427&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Jounce Therapeutics, Inc.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">322,276&#160;</td><td align="right" valign="bottom">4,511,864&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Juno Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">451,511&#160;</td><td align="right" valign="bottom">20,277,359&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Karyopharm Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,093,531&#160;</td><td align="right" valign="bottom">11,164,952&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Keryx Biopharmaceuticals, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">351,839&#160;</td><td align="right" valign="bottom">2,279,917&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Krystal Biotech, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">264,600&#160;</td><td align="right" valign="bottom">2,619,540&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Kura Oncology, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">878,202&#160;</td><td align="right" valign="bottom">13,085,210&#160;</td>
</tr>
<tr>
<td align="left" valign="top">La Jolla Pharmaceutical Co.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">348,100&#160;</td><td align="right" valign="bottom">11,960,716&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Lexicon Pharmaceuticals, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">565,966&#160;</td><td align="right" valign="bottom">5,767,194&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ligand Pharmaceuticals, Inc. Class B (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">82,112&#160;</td><td align="right" valign="bottom">11,934,979&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Loxo Oncology, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">365,781&#160;</td><td align="right" valign="bottom">31,515,691&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Macrogenics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">566,002&#160;</td><td align="right" valign="bottom">11,201,180&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Madrigal Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">119,856&#160;</td><td align="right" valign="bottom">5,991,601&#160;</td>
</tr>
<tr>
<td align="left" valign="top">MannKind Corp.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">398,539&#160;</td><td align="right" valign="bottom">1,311,193&#160;</td>
</tr>
<tr>
<td align="left" valign="top">MediciNova, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">388,780&#160;</td><td align="right" valign="bottom">2,764,226&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Merrimack Pharmaceuticals, Inc.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">68,240&#160;</td><td align="right" valign="bottom">801,138&#160;</td>
</tr>
<tr>
<td align="left" valign="top">MiMedx Group, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">12,313&#160;</td><td align="right" valign="bottom">156,129&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Minerva Neurosciences, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,788,152&#160;</td><td align="right" valign="bottom">11,265,358&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Miragen Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">658,541&#160;</td><td align="right" valign="bottom">5,452,719&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Molecular Templates, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">2,436&#160;</td><td align="right" valign="bottom">19,391&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Momenta Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">165,625&#160;</td><td align="right" valign="bottom">2,335,313&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NantKwest, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">70,253&#160;</td><td align="right" valign="bottom">324,569&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Neurocrine Biosciences, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">604,728&#160;</td><td align="right" valign="bottom">37,559,656&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NewLink Genetics Corp.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">114,392&#160;</td><td align="right" valign="bottom">1,070,709&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Novavax, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,171,816&#160;</td><td align="right" valign="bottom">1,277,279&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Novelion Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">216,270&#160;</td><td align="right" valign="bottom">1,020,794&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Opko Health, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">137,912&#160;</td><td align="right" valign="bottom">928,148&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Oragenics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">108,608&#160;</td><td align="right" valign="bottom">36,938&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Osiris Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">6,862&#160;</td><td align="right" valign="bottom">34,310&#160;</td>
</tr>
<tr>
<td align="left" valign="top">OvaScience, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">105,645&#160;</td><td align="right" valign="bottom">160,580&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ovid Therapeutics, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">124,400&#160;</td><td align="right" valign="bottom">806,112&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ovid Therapeutics, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">114,626&#160;</td><td align="right" valign="bottom">735,349&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Portola Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">557,324&#160;</td><td align="right" valign="bottom">27,537,379&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Progenics Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">438,108&#160;</td><td align="right" valign="bottom">2,711,889&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ProQR Therapeutics BV  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">237,916&#160;</td><td align="right" valign="bottom">904,081&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Protagonist Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">170,723&#160;</td><td align="right" valign="bottom">2,555,723&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Proteostasis Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">183,300&#160;</td><td align="right" valign="bottom">344,604&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Prothena Corp. PLC  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">140,434&#160;</td><td align="right" valign="bottom">8,152,194&#160;</td>
</tr>
<tr>
<td align="left" valign="top">PTC Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">260,709&#160;</td><td align="right" valign="bottom">4,885,687&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Puma Biotechnology, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">287,902&#160;</td><td align="right" valign="bottom">36,649,925&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Radius Health, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">674,729&#160;</td><td align="right" valign="bottom">21,665,548&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Regeneron Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">264,187&#160;</td><td align="right" valign="bottom">106,366,970&#160;</td>
</tr>
<tr>
<td align="left" valign="top">REGENXBIO, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">333,286&#160;</td><td align="right" valign="bottom">9,981,916&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Regulus Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">960,221&#160;</td><td align="right" valign="bottom">960,221&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Repligen Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">234,327&#160;</td><td align="right" valign="bottom">8,716,964&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Retrophin, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">353,572&#160;</td><td align="right" valign="bottom">8,793,336&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Rigel Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">179,900&#160;</td><td align="right" valign="bottom">674,625&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sage Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">258,068&#160;</td><td align="right" valign="bottom">16,330,543&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sangamo Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,192,016&#160;</td><td align="right" valign="bottom">14,780,998&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sarepta Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">274,611&#160;</td><td align="right" valign="bottom">13,541,068&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Seattle Genetics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">559,320&#160;</td><td align="right" valign="bottom">34,291,909&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Selecta Biosciences, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">88,000&#160;</td><td align="right" valign="bottom">1,867,360&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Seres Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">237,191&#160;</td><td align="right" valign="bottom">2,381,398&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Seres Therapeutics, Inc.  (a)(c)&#160;</td><td valign="top"/><td align="right" valign="bottom">352,270&#160;</td><td align="right" valign="bottom">3,536,791&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sienna Biopharmaceuticals, Inc.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">61,493&#160;</td><td align="right" valign="bottom">1,205,263&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Spark Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">314,145&#160;</td><td align="right" valign="bottom">25,414,331&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Spectrum Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,239,512&#160;</td><td align="right" valign="bottom">24,282,040&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Stemline Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">400,493&#160;</td><td align="right" valign="bottom">5,466,729&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Syndax Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">219,099&#160;</td><td align="right" valign="bottom">2,449,527&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Synlogic, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">4,028&#160;</td><td align="right" valign="bottom">58,849&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Syros Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">152,478&#160;</td><td align="right" valign="bottom">2,622,622&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Syros Pharmaceuticals, Inc.  (c)&#160;</td><td valign="top"/><td align="right" valign="bottom">62,568&#160;</td><td align="right" valign="bottom">1,076,170&#160;</td>
</tr>
<tr>
<td align="left" valign="top">TESARO, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">256,437&#160;</td><td align="right" valign="bottom">29,687,711&#160;</td>
</tr>
<tr>
<td align="left" valign="top">TG Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,402,202&#160;</td><td align="right" valign="bottom">11,427,946&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Tocagen, Inc.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">154,600&#160;</td><td align="right" valign="bottom">1,711,422&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Trevena, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">296,455&#160;</td><td align="right" valign="bottom">444,683&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ultragenyx Pharmaceutical, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">404,027&#160;</td><td align="right" valign="bottom">18,621,604&#160;</td>
</tr>
<tr>
<td align="left" valign="top">uniQure B.V. (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">31,152&#160;</td><td align="right" valign="bottom">464,165&#160;</td>
</tr>
<tr>
<td align="left" valign="top">United Therapeutics Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">49,723&#160;</td><td align="right" valign="bottom">5,896,651&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Vanda Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">337,679&#160;</td><td align="right" valign="bottom">5,301,560&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Vertex Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">718,728&#160;</td><td align="right" valign="bottom">105,099,595&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Vical, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">54,186&#160;</td><td align="right" valign="bottom">119,209&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Vital Therapies, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">588,087&#160;</td><td align="right" valign="bottom">3,469,713&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Voyager Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,280,677&#160;</td><td align="right" valign="bottom">26,971,058&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Xencor, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">378,226&#160;</td><td align="right" valign="bottom">7,481,310&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Zafgen, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,356,174&#160;</td><td align="right" valign="bottom">4,827,979&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Zealand Pharma A/S  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">112,234&#160;</td><td align="right" valign="bottom">2,073,120&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Zealand Pharma A/S sponsored ADR&#160;</td><td valign="top"/><td align="right" valign="bottom">33,700&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">622,439&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">2,326,923,836&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Diversified Financial Services - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Other Diversified Financial Services - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">RPI International Holdings LP  (a)(d)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">12,210&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,666,970&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Equipment &amp; Supplies - 0.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Equipment - 0.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Bellerophon Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">186,300&#160;</td><td align="right" valign="bottom">255,231&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Novocure Ltd.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">243,941&#160;</td><td align="right" valign="bottom">5,269,126&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Novocure Ltd.  (a)(c)&#160;</td><td valign="top"/><td align="right" valign="bottom">155,553&#160;</td><td align="right" valign="bottom">3,359,945&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Vermillion, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">991,800&#160;</td><td align="right" valign="bottom">1,438,110&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Zosano Pharma Corp.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">530,003&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">355,102&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">10,677,514&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Providers &amp; Services - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Services - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">G1 Therapeutics, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">232,700&#160;</td><td align="right" valign="bottom">5,498,701&#160;</td>
</tr>
<tr>
<td align="left" valign="top">OptiNose, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">46,600&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">939,456&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">6,438,157&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Technology - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Technology - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NantHealth, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">49,200&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">179,580&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Life Sciences Tools &amp; Services - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Life Sciences Tools &amp; Services - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Morphosys AG  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">5,400&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">468,997&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Personal Products - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Personal Products - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">MYOS Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">6,666&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">8,799&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Pharmaceuticals - 8.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Pharmaceuticals - 8.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Aclaris Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">166,983&#160;</td><td align="right" valign="bottom">4,209,641&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Adimab LLC  (a)(d)(e)(f)&#160;</td><td valign="top"/><td align="right" valign="bottom">398,401&#160;</td><td align="right" valign="bottom">13,649,218&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Afferent Pharmaceuticals, Inc. rights 12/31/24 (a)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,915,787&#160;</td><td align="right" valign="bottom">1,954,103&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Akcea Therapeutics, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">184,300&#160;</td><td align="right" valign="bottom">3,376,376&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Aradigm Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">545&#160;</td><td align="right" valign="bottom">2,273&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Aradigm Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">8,241&#160;</td><td align="right" valign="bottom">34,365&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Avexis, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">207,762&#160;</td><td align="right" valign="bottom">21,713,207&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Axsome Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">605,360&#160;</td><td align="right" valign="bottom">2,875,460&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cempra, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,042,678&#160;</td><td align="right" valign="bottom">2,398,159&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Clementia Pharmaceuticals, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">109,500&#160;</td><td align="right" valign="bottom">1,754,190&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Corcept Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">168,373&#160;</td><td align="right" valign="bottom">3,315,264&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Dermira, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">475,445&#160;</td><td align="right" valign="bottom">12,727,663&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Dova Pharmaceuticals, Inc.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">338,516&#160;</td><td align="right" valign="bottom">8,483,211&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Egalet Corp.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,007,174&#160;</td><td align="right" valign="bottom">987,031&#160;</td>
</tr>
<tr>
<td align="left" valign="top">GW Pharmaceuticals PLC ADR  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">119,033&#160;</td><td align="right" valign="bottom">12,849,612&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Horizon Pharma PLC  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">228,856&#160;</td><td align="right" valign="bottom">3,103,287&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Intra-Cellular Therapies, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">175,454&#160;</td><td align="right" valign="bottom">2,735,328&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Jazz Pharmaceuticals PLC  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">77,567&#160;</td><td align="right" valign="bottom">10,978,058&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Kala Pharmaceuticals, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">131,500&#160;</td><td align="right" valign="bottom">2,111,890&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Kolltan Pharmaceuticals, Inc. rights(a)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,610,391&#160;</td><td align="right" valign="bottom">241,559&#160;</td>
</tr>
<tr>
<td align="left" valign="top">MyoKardia, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">192,192&#160;</td><td align="right" valign="bottom">7,389,782&#160;</td>
</tr>
<tr>
<td align="left" valign="top">MyoKardia, Inc.  (a)(c)&#160;</td><td valign="top"/><td align="right" valign="bottom">484,646&#160;</td><td align="right" valign="bottom">18,634,639&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Nektar Therapeutics  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">117,948&#160;</td><td align="right" valign="bottom">2,841,367&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NeurogesX, Inc. (a)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">150,000&#160;</td><td align="right" valign="bottom">2&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ocular Therapeutix, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">220,171&#160;</td><td align="right" valign="bottom">1,268,185&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Pacira Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">125,384&#160;</td><td align="right" valign="bottom">4,018,557&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Paratek Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">433,460&#160;</td><td align="right" valign="bottom">9,276,044&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Reata Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">169,094&#160;</td><td align="right" valign="bottom">5,120,166&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Repros Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">534,054&#160;</td><td align="right" valign="bottom">269,110&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Rhythm Pharmaceuticals, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">80,655&#160;</td><td align="right" valign="bottom">2,063,155&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Stemcentrx, Inc. rights 12/31/21 (a)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">208,907&#160;</td><td align="right" valign="bottom">614,187&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Tetraphase Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">309,731&#160;</td><td align="right" valign="bottom">1,861,483&#160;</td>
</tr>
<tr>
<td align="left" valign="top">The Medicines Company  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">368,922&#160;</td><td align="right" valign="bottom">10,602,818&#160;</td>
</tr>
<tr>
<td align="left" valign="top">TherapeuticsMD, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,087,400&#160;</td><td align="right" valign="bottom">5,132,528&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Theravance Biopharma, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">213,103&#160;</td><td align="right" valign="bottom">6,150,153&#160;</td>
</tr>
<tr>
<td align="left" valign="top">UroGen Pharma Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">166,900&#160;</td><td align="right" valign="bottom">5,295,737&#160;</td>
</tr>
<tr>
<td align="left" valign="top">WAVE Life Sciences  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">338,988&#160;</td><td align="right" valign="bottom">7,813,673&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Zogenix, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">319,749&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">11,990,588&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">209,842,069&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Software - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Application Software - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Precipio, Inc.  (d)&#160;</td><td valign="top"/><td align="right" valign="bottom">450&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">878&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL COMMON STOCKS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $2,021,800,532)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">2,556,206,800&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Preferred Stocks - 1.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Convertible Preferred Stocks - 1.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Biotechnology - 1.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Biotechnology - 1.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">23andMe, Inc. Series E  (a)(d)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">341,730&#160;</td><td align="right" valign="bottom">4,744,648&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Allena Pharmaceuticals, Inc. Series C  (a)(d)&#160;</td><td valign="top"/><td align="right" valign="bottom">360,694&#160;</td><td align="right" valign="bottom">4,544,744&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Axcella Health, Inc. Series C  (a)(d)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">341,857&#160;</td><td align="right" valign="bottom">3,445,919&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Immunocore Ltd. Series A  (a)(d)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">17,149&#160;</td><td align="right" valign="bottom">5,972,439&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Moderna Therapeutics, Inc.:&#160;</td><td valign="top"/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Series D  (a)(d)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">269,180&#160;</td><td align="right" valign="bottom">1,940,788&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Series E  (a)(d)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">544,100&#160;</td><td align="right" valign="bottom">3,922,961&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Scholar Rock LLC Series B  (a)(d)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,083,994&#160;</td><td align="right" valign="bottom">3,501,301&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Translate Bio:&#160;</td><td valign="top"/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Series B  (a)(d)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,310,353&#160;</td><td align="right" valign="bottom">3,760,713&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Series C  (d)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,010,101&#160;</td><td align="right" valign="bottom">2,898,990&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Twist Bioscience Corp.:&#160;</td><td valign="top"/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Series C  (a)(d)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,866,791&#160;</td><td align="right" valign="bottom">4,005,573&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Series D  (a)(d)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">453,587&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">973,262&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">39,711,338&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Technology - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Health Care Technology - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Codiak Biosciences, Inc.:&#160;</td><td valign="top"/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Series A  (a)(d)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">213,402&#160;</td><td align="right" valign="bottom">704,227&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Series B  (a)(d)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">693,558&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,288,741&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,992,968&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Pharmaceuticals - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Pharmaceuticals - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Afferent Pharmaceuticals, Inc. Series C  (a)(d)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,915,787&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">938,736&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL CONVERTIBLE PREFERRED STOCKS&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">43,643,042&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Nonconvertible Preferred Stocks - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Biotechnology - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Biotechnology - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Yumanity Holdings LLC Class A  (a)(d)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">151,084&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,689,119&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL PREFERRED STOCKS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $32,910,045)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">45,332,161&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Money Market Funds - 8.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund, 1.10% (g)&#160;</td><td valign="top"/><td align="right" valign="bottom">23,857,907&#160;</td><td align="right" valign="bottom">23,862,679&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund 1.11% (g)(h)&#160;</td><td valign="top"/><td align="right" valign="bottom">201,588,017&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">201,608,176&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL MONEY MARKET FUNDS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $225,456,898)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">225,470,855&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL INVESTMENT IN SECURITIES - 107.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">(Cost $2,280,167,475)&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td style="font-weight: bold;" align="right" valign="top">2,827,009,816&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET OTHER ASSETS (LIABILITIES) - (7.7)%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">(203,242,266)&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET ASSETS - 100%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: double 3px black; font-weight: bold;">$2,623,767,550&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 12pt Arial, Helvetica, sans-serif;">Legend</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(a)&#160;Non-income producing</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(b)&#160;Security or a portion of the security is on loan at period end.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(c)&#160;Security exempt from registration under Rule 144A of the Securities Act of 1933.  These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $29,896,453 or 1.1% of net assets.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(d)&#160;Restricted securities - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues).  At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $60,649,226 or 2.3% of net assets.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(e)&#160;Level 3 security</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(f)&#160;Investment is owned by a wholly-owned subsidiary (Subsidiary) that is treated as a corporation for U.S. tax purposes.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(g)&#160;Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(h)&#160;Investment made with cash collateral received from securities on loan.</p>
<br/>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Additional information on each restricted holding is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Security&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Acquisition Date&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Acquisition Cost&#160;</td>
</tr>
<tr>
<td align="left" valign="top">23andMe, Inc. Series E&#160;</td><td align="right" valign="bottom">6/18/15&#160;</td><td align="right" valign="bottom">$3,700,003&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Adimab LLC&#160;</td><td align="right" valign="bottom">9/17/14 - 6/5/15&#160;</td><td align="right" valign="bottom">$6,416,091&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Afferent Pharmaceuticals, Inc. Series C&#160;</td><td align="right" valign="bottom">7/1/15&#160;</td><td align="right" valign="bottom">$862,104&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Allena Pharmaceuticals, Inc. Series C&#160;</td><td align="right" valign="bottom">11/25/15&#160;</td><td align="right" valign="bottom">$3,989,676&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Axcella Health, Inc. Series C&#160;</td><td align="right" valign="bottom">1/30/15&#160;</td><td align="right" valign="bottom">$3,445,919&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Codiak Biosciences, Inc. Series A&#160;</td><td align="right" valign="bottom">11/12/15&#160;</td><td align="right" valign="bottom">$213,402&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Codiak Biosciences, Inc. Series B&#160;</td><td align="right" valign="bottom">11/12/15&#160;</td><td align="right" valign="bottom">$2,080,674&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Immunocore Ltd. Series A&#160;</td><td align="right" valign="bottom">7/27/15&#160;</td><td align="right" valign="bottom">$3,227,085&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Moderna Therapeutics, Inc. Series D&#160;</td><td align="right" valign="bottom">11/6/13&#160;</td><td align="right" valign="bottom">$1,300,630&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Moderna Therapeutics, Inc. Series E&#160;</td><td align="right" valign="bottom">12/18/14&#160;</td><td align="right" valign="bottom">$2,628,996&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Precipio, Inc.&#160;</td><td align="right" valign="bottom">2/3/12 - 7/31/17&#160;</td><td align="right" valign="bottom">$161,441&#160;</td>
</tr>
<tr>
<td align="left" valign="top">RPI International Holdings LP&#160;</td><td align="right" valign="bottom">5/21/15&#160;</td><td align="right" valign="bottom">$1,439,559&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Scholar Rock LLC Series B&#160;</td><td align="right" valign="bottom">12/17/15&#160;</td><td align="right" valign="bottom">$3,251,982&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Translate Bio Series B&#160;</td><td align="right" valign="bottom">7/17/15&#160;</td><td align="right" valign="bottom">$1,415,181&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Translate Bio Series C&#160;</td><td align="right" valign="bottom">12/22/16&#160;</td><td align="right" valign="bottom">$2,000,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Twist Bioscience Corp. Series C&#160;</td><td align="right" valign="bottom">5/29/15&#160;</td><td align="right" valign="bottom">$2,800,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Twist Bioscience Corp. Series D&#160;</td><td align="right" valign="bottom">1/8/16&#160;</td><td align="right" valign="bottom">$973,262&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Yumanity Holdings LLC Class A&#160;</td><td align="right" valign="bottom">2/8/16&#160;</td><td align="right" valign="bottom">$1,021,131&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Affiliated Central Funds</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Fund&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Income earned&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund&#160;</td><td align="right" valign="bottom">$42,279&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">831,169&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Total&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$873,448&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investment Valuation</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">The following is a summary of the inputs used, as of October 31, 2017, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. Additional information on valuation inputs, and their aggregation into the levels used below, is provided later in this section.</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td style="font-weight: bold;" align="center" valign="bottom" colspan="4">Valuation Inputs at Reporting Date:&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Description&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Total&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 1&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 2&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 3&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top"><u>Investments in Securities:</u>&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Common Stocks&#160;</td><td align="right" valign="bottom">$2,556,206,800&#160;</td><td align="right" valign="bottom">$2,537,312,493&#160;</td><td align="right" valign="bottom">$768,268&#160;</td><td align="right" valign="bottom">$18,126,039&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Preferred Stocks&#160;</td><td align="right" valign="bottom">45,332,161&#160;</td><td align="right" valign="bottom">--&#160;</td><td align="right" valign="bottom">4,544,744&#160;</td><td align="right" valign="bottom">40,787,417&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Money Market Funds&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">225,470,855&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">225,470,855&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td>
</tr>
<tr>
<td style="font-weight: bold" valign="top">Total Investments in Securities:&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$2,827,009,816&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$2,762,783,348&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$5,313,012&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$58,913,456&#160;</td>
</tr>
</table>
<br/>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">The following is a reconciliation of Investments in Securities for which Level 3 inputs were used in determining value:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font-weight:bold;">
<td align="left" valign="top">Investments in Securities:&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="border-bottom: solid 1px black;">Preferred Stocks&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Beginning Balance&#160;</td><td align="right" valign="bottom">$43,160,615&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Total Realized Gain (Loss)&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Total Unrealized Gain (Loss)&#160;</td><td align="right" valign="bottom">1,691,755&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Cost of Purchases&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Proceeds of Sales&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Amortization/Accretion&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Transfers in to Level 3&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Transfers out of Level 3&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">(4,064,953)&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Ending Balance&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$40,787,417&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">The change in unrealized gain (loss) for the period attributable to Level 3 securities held at October 31, 2017&#160;</td><td align="right" valign="bottom">$1,691,755&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="border-bottom: solid 1px black;">Other Investments in Securities&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Beginning Balance&#160;</td><td align="right" valign="bottom">$18,025,736&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Total Realized Gain (Loss)&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Total Unrealized Gain (Loss)&#160;</td><td align="right" valign="bottom">89,983&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Cost of Purchases&#160;</td><td align="right" valign="bottom">10,320&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Proceeds of Sales&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Amortization/Accretion&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Transfers in to Level 3&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Transfers out of Level 3&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Ending Balance&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$18,126,039&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">The change in unrealized gain (loss) for the period attributable to Level 3 securities held at October 31, 2017&#160;</td><td align="right" valign="bottom">$89,983&#160;</td>
</tr>
</table>
<br/>
<p style="font: italic 10pt Arial, Helvetica, sans-serif;">The information used in the above reconciliations represents fiscal year to date activity for any Investments in Securities identified as using Level 3 inputs at either the beginning or the end of the current fiscal period. Transfers in or out of Level 3 represent the beginning value of any Security or Instrument where a change in the pricing level occurred from the beginning to the end of the period. The cost of purchases and the proceeds of sales may include securities received or delivered through corporate actions or exchanges.</p>
<p>Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund&#146;s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:</p>
<p>Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. Utilizing these techniques may result in transfers between Level 1 and Level 2. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy. Equity securities, including restricted securities, for which observable inputs are not available, are valued using alternate valuation approaches, including the market approach and the income approach and are categorized as Level 3 in the hierarchy. The market approach generally consists of using comparable market transactions while the income approach generally consists of using the net present value of estimated future cash flows, adjusted as appropriate for liquidity, credit, market and/or other risk factors.</p>
<p>Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.</p>
<p>The following provides information on Level 3 securities held by the fund that were valued at period end based on unobservable inputs. These amounts exclude valuations provided by a broker.</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Asset Type&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Fair Value&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Valuation Technique (s)&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Unobservable Input&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Amount or Range / Weighted Average&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Impact to Valuation from an Increase in Input(a)&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Equities&#160;</td><td align="right" valign="bottom">$58,913,456&#160;</td><td align="right" valign="bottom">Market approach&#160;</td><td align="right" valign="bottom">Transaction price&#160;</td><td align="right" valign="bottom">$2.15 - $13.88 / $7.87&#160;</td><td align="right" valign="bottom">Increase&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">Market comparable&#160;</td><td align="right" valign="bottom">Transaction price&#160;</td><td align="right" valign="bottom">$1.98 - $199.22 / $43.22&#160;</td><td align="right" valign="bottom">Increase&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">Premium rate&#160;</td><td align="right" valign="bottom">15.0%&#160;</td><td align="right" valign="bottom">Increase&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">Proxy premium&#160;</td><td align="right" valign="bottom">7.7% - 76.0% / 34.4%&#160;</td><td align="right" valign="bottom">Increase&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">Recovery value&#160;</td><td align="right" valign="bottom">Recovery value&#160;</td><td align="right" valign="bottom">0.0%&#160;</td><td align="right" valign="bottom">Increase&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">Discount cash flow&#160;</td><td align="right" valign="bottom">Discount rate&#160;</td><td align="right" valign="bottom">8.0% - 12.2% / 10.6%&#160;</td><td align="right" valign="bottom">Decrease&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">Discount for lack of marketability&#160;</td><td align="right" valign="bottom">10.0%&#160;</td><td align="right" valign="bottom">Decrease&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">Probability rate&#160;</td><td align="right" valign="bottom">6.3% - 68.9% / 7.4%&#160;</td><td align="right" valign="bottom">Increase&#160;</td>
</tr>
</table>
<br/>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(a)&#160;<i>Represents the expected directional change in the fair value of the Level 3 investments that would result from an increase in the corresponding input. A decrease to the unobservable input would have the opposite effect. Significant changes in these inputs could result in significantly higher or lower fair value measurements.</i>
</p>
<br/>
<p>For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.</p>
<br/>
<br/>
<br/>
<br/>
<p style="font-style: italic;">
</p><p style="font-style: italic;">The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.</p>

<p style="font-style: italic;">
</p><p style="font-style: italic;">Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.</p>

<hr size="2" noshade="noshade"/>
</div>
<div style="font: normal 11pt Arial, Helvetica, sans-serif; width: 780px">
<!-- Automatically produced using the ProofPlus Content Management System -->
<p style="font: bold 18pt Arial, Helvetica, sans-serif; margin-bottom: 0px;" align="center">Quarterly Holdings Report<br clear="all"/>for</p>
<p style="font: bold 20pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">Fidelity Advisor&#174; Communications Equipment Fund</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">October 31, 2017</p>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>AFDC-QTLY-1217<br/>1.809086.114<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<a name="">
<p style="font: bold 16pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investments October 31, 2017 (Unaudited)</p>
</a>
<p style="font: normal 11pt Arial, Helvetica, sans-serif; margin-top: 0px;">Showing Percentage of Net Assets</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="0" cellpadding="5" width="745">
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Common Stocks - 98.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td/><td style="font-weight: bold;" align="center" valign="bottom">Shares&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Value&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Communications Equipment - 87.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Communications Equipment - 87.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ADTRAN, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">9,170&#160;</td><td align="right" valign="bottom">$193,487&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Arista Networks, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,150&#160;</td><td align="right" valign="bottom">229,874&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Arris International PLC  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">8,262&#160;</td><td align="right" valign="bottom">235,467&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Brocade Communications Systems, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">40,495&#160;</td><td align="right" valign="bottom">471,767&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Calix Networks, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">25,140&#160;</td><td align="right" valign="bottom">138,270&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ciena Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,050&#160;</td><td align="right" valign="bottom">22,334&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cisco Systems, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">102,594&#160;</td><td align="right" valign="bottom">3,503,582&#160;</td>
</tr>
<tr>
<td align="left" valign="top">CommScope Holding Co., Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">27,470&#160;</td><td align="right" valign="bottom">882,886&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Comtech Telecommunications Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">930&#160;</td><td align="right" valign="bottom">20,004&#160;</td>
</tr>
<tr>
<td align="left" valign="top">EchoStar Holding Corp. Class A (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,690&#160;</td><td align="right" valign="bottom">94,556&#160;</td>
</tr>
<tr>
<td align="left" valign="top">F5 Networks, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">5,775&#160;</td><td align="right" valign="bottom">700,334&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Finisar Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">12,750&#160;</td><td align="right" valign="bottom">300,135&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Harmonic, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,250&#160;</td><td align="right" valign="bottom">4,625&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Harris Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">7,330&#160;</td><td align="right" valign="bottom">1,021,216&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Infinera Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">17,937&#160;</td><td align="right" valign="bottom">150,133&#160;</td>
</tr>
<tr>
<td align="left" valign="top">InterDigital, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">2,970&#160;</td><td align="right" valign="bottom">217,850&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Juniper Networks, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">27,548&#160;</td><td align="right" valign="bottom">684,017&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Lumentum Holdings, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">3,750&#160;</td><td align="right" valign="bottom">236,813&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Mitel Networks Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">13,720&#160;</td><td align="right" valign="bottom">117,855&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Motorola Solutions, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">2,679&#160;</td><td align="right" valign="bottom">242,557&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NETGEAR, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,500&#160;</td><td align="right" valign="bottom">69,975&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NetScout Systems, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">4,660&#160;</td><td align="right" valign="bottom">132,344&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Nokia Corp. sponsored ADR  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">192,680&#160;</td><td align="right" valign="bottom">942,205&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Oclaro, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">11,230&#160;</td><td align="right" valign="bottom">92,872&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Palo Alto Networks, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">2,570&#160;</td><td align="right" valign="bottom">378,304&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Plantronics, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">2,050&#160;</td><td align="right" valign="bottom">92,988&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Radware Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">4,090&#160;</td><td align="right" valign="bottom">71,739&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sonus Networks, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">12,460&#160;</td><td align="right" valign="bottom">97,188&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Telefonaktiebolaget LM Ericsson (B Shares) sponsored ADR  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">106,570&#160;</td><td align="right" valign="bottom">666,063&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ViaSat, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">370&#160;</td><td align="right" valign="bottom">24,087&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Viavi Solutions, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">29,330&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">272,182&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">12,307,709&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Diversified Financial Services - 0.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Other Diversified Financial Services - 0.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Quantenna Communications, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">3,500&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">54,215&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electronic Equipment &amp; Components - 2.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electronic Manufacturing Services - 1.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fabrinet  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">2,030&#160;</td><td align="right" valign="bottom">75,475&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Jabil, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">2,850&#160;</td><td align="right" valign="bottom">80,598&#160;</td>
</tr>
<tr>
<td align="left" valign="top">TE Connectivity Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">360&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">32,749&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">188,822&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Technology Distributors - 0.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">CDW Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">790&#160;</td><td align="right" valign="bottom">55,300&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Dell Technologies, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">424&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">35,094&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">90,394&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL ELECTRONIC EQUIPMENT &amp; COMPONENTS&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">279,216&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet Software &amp; Services - 2.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet Software &amp; Services - 2.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Akamai Technologies, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">310&#160;</td><td align="right" valign="bottom">16,198&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Alphabet, Inc.:&#160;</td><td valign="top"/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Class A (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">129&#160;</td><td align="right" valign="bottom">133,262&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Class C (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">108&#160;</td><td align="right" valign="bottom">109,797&#160;</td>
</tr>
<tr>
<td align="left" valign="top">LogMeIn, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">310&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">37,526&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">296,783&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">IT Services - 1.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Data Processing &amp; Outsourced Services - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">WNS Holdings Ltd. sponsored ADR  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">400&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">15,168&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">IT Consulting &amp; Other Services - 0.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cognizant Technology Solutions Corp. Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">570&#160;</td><td align="right" valign="bottom">43,132&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Presidio, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">5,910&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">87,468&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">130,600&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL IT SERVICES&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">145,768&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Semiconductors &amp; Semiconductor Equipment - 4.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Semiconductors - 4.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Acacia Communications, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">2,220&#160;</td><td align="right" valign="bottom">93,928&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Broadcom Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">275&#160;</td><td align="right" valign="bottom">72,575&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Maxim Integrated Products, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,240&#160;</td><td align="right" valign="bottom">65,150&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ON Semiconductor Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">2,670&#160;</td><td align="right" valign="bottom">56,924&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Qualcomm, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">5,491&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">280,096&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">568,673&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Software - 1.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Application Software - 0.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Citrix Systems, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">600&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">49,566&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Systems Software - 1.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Check Point Software Technologies Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">740&#160;</td><td align="right" valign="bottom">87,105&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Oracle Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,300&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">66,170&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">153,275&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL SOFTWARE&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">202,841&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Technology Hardware, Storage &amp; Peripherals - 0.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Technology Hardware, Storage &amp; Peripherals - 0.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">HP, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,730&#160;</td><td align="right" valign="bottom">37,282&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Samsung Electronics Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">26&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">64,041&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">101,323&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL COMMON STOCKS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $10,585,485)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">13,956,528&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Money Market Funds - 10.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund, 1.10% (c)&#160;</td><td valign="top"/><td align="right" valign="bottom">90,692&#160;</td><td align="right" valign="bottom">90,710&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund 1.11%(c)(d)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,390,903&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,391,042&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL MONEY MARKET FUNDS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $1,481,752)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">1,481,752&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL INVESTMENT IN SECURITIES - 109.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">(Cost $12,067,237)&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td style="font-weight: bold;" align="right" valign="top">15,438,280&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET OTHER ASSETS (LIABILITIES) - (9.3)%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">(1,316,127)&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET ASSETS - 100%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: double 3px black; font-weight: bold;">$14,122,153&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 12pt Arial, Helvetica, sans-serif;">Legend</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(a)&#160;Non-income producing</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(b)&#160;Security or a portion of the security is on loan at period end.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(c)&#160;Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(d)&#160;Investment made with cash collateral received from securities on loan.</p>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Affiliated Central Funds</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Fund&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Income earned&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund&#160;</td><td align="right" valign="bottom">$192&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,959&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Total&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$5,151&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investment Valuation</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">All investments are categorized as Level 1 under the Fair Value Hierarchy. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. Additional information on valuation inputs is provided later in this section.</p>
<p>Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund&#146;s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:</p>
<p>Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. Utilizing these techniques may result in transfers between Level 1 and Level 2. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.</p>
<p>Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.</p>
<p>For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.</p>
<br/>
<br/>
<br/>
<br/>
<p style="font-style: italic;">
</p><p style="font-style: italic;">The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.</p>

<p style="font-style: italic;">
</p><p style="font-style: italic;">Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.</p>

<hr size="2" noshade="noshade"/>
</div>
<div style="font: normal 11pt Arial, Helvetica, sans-serif; width: 780px">
<!-- Automatically produced using the ProofPlus Content Management System -->
<p style="font: bold 18pt Arial, Helvetica, sans-serif; margin-bottom: 0px;" align="center">Quarterly Holdings Report<br clear="all"/>for</p>
<p style="font: bold 20pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">Fidelity Advisor&#174; Consumer Discretionary Fund</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">October 31, 2017</p>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>AFCI-QTLY-1217<br/>1.809085.114<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<a name="">
<p style="font: bold 16pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investments October 31, 2017 (Unaudited)</p>
</a>
<p style="font: normal 11pt Arial, Helvetica, sans-serif; margin-top: 0px;">Showing Percentage of Net Assets</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="0" cellpadding="5" width="745">
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Common Stocks - 99.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td/><td style="font-weight: bold;" align="center" valign="bottom">Shares&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Value&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Air Freight &amp; Logistics - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Air Freight &amp; Logistics - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">XPO Logistics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">3,500&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">$242,725&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Auto Components - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Auto Parts &amp; Equipment - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Tenneco, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">400&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">23,244&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Automobiles - 2.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Automobile Manufacturers - 2.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ferrari NV&#160;</td><td valign="top"/><td align="right" valign="bottom">4,700&#160;</td><td align="right" valign="bottom">562,496&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Tesla, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">15,700&#160;</td><td align="right" valign="bottom">5,205,021&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Thor Industries, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">2,300&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">313,306&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">6,080,823&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Beverages - 1.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Distillers &amp; Vintners - 0.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Constellation Brands, Inc. Class A (sub. vtg.)&#160;</td><td valign="top"/><td align="right" valign="bottom">10,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,190,900&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Soft Drinks - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Monster Beverage Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">6,216&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">360,093&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL BEVERAGES&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">2,550,993&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Commercial Services &amp; Supplies - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Diversified Support Services - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Copart, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">11,500&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">417,335&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Distributors - 0.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Distributors - 0.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">LKQ Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">41,200&#160;</td><td align="right" valign="bottom">1,552,828&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Pool Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">4,500&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">543,510&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">2,096,338&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Diversified Consumer Services - 0.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Education Services - 0.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Grand Canyon Education, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">4,400&#160;</td><td align="right" valign="bottom">393,844&#160;</td>
</tr>
<tr>
<td align="left" valign="top">New Oriental Education &amp; Technology Group, Inc. sponsored ADR&#160;</td><td valign="top"/><td align="right" valign="bottom">3,400&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">283,016&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">676,860&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Specialized Consumer Services - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Service Corp. International&#160;</td><td valign="top"/><td align="right" valign="bottom">4,200&#160;</td><td align="right" valign="bottom">148,932&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ServiceMaster Global Holdings, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">8,600&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">405,146&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">554,078&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL DIVERSIFIED CONSUMER SERVICES&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">1,230,938&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Food &amp; Staples Retailing - 1.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Food Distributors - 0.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Performance Food Group Co.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">76,400&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,162,120&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Hypermarkets &amp; Super Centers - 0.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Costco Wholesale Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">5,900&#160;</td><td align="right" valign="bottom">950,372&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Wal-Mart Stores, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">3,100&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">270,661&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">1,221,033&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL FOOD &amp; STAPLES RETAILING&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">3,383,153&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Hotels, Restaurants &amp; Leisure - 26.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Casinos &amp; Gaming - 4.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Caesars Entertainment Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">24,300&#160;</td><td align="right" valign="bottom">314,685&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Churchill Downs, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">4,600&#160;</td><td align="right" valign="bottom">959,330&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Eldorado Resorts, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">29,600&#160;</td><td align="right" valign="bottom">760,720&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Las Vegas Sands Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">72,080&#160;</td><td align="right" valign="bottom">4,568,430&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Melco Crown Entertainment Ltd. sponsored ADR&#160;</td><td valign="top"/><td align="right" valign="bottom">20,900&#160;</td><td align="right" valign="bottom">528,352&#160;</td>
</tr>
<tr>
<td align="left" valign="top">MGM Mirage, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">86,000&#160;</td><td align="right" valign="bottom">2,696,100&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Penn National Gaming, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">23,696&#160;</td><td align="right" valign="bottom">618,229&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Wynn Resorts Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">5,300&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">781,697&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">11,227,543&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Hotels, Resorts &amp; Cruise Lines - 8.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Carnival Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">22,900&#160;</td><td align="right" valign="bottom">1,520,331&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Hilton Grand Vacations, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">12,700&#160;</td><td align="right" valign="bottom">520,192&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Hilton, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">70,300&#160;</td><td align="right" valign="bottom">5,081,284&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ILG, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">9,100&#160;</td><td align="right" valign="bottom">269,997&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Marriott International, Inc. Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">35,175&#160;</td><td align="right" valign="bottom">4,202,709&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Marriott Vacations Worldwide Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">10,300&#160;</td><td align="right" valign="bottom">1,355,686&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Royal Caribbean Cruises Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">38,300&#160;</td><td align="right" valign="bottom">4,740,391&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Wyndham Worldwide Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">36,120&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">3,859,422&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">21,550,012&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Leisure Facilities - 1.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cedar Fair LP (depositary unit)&#160;</td><td valign="top"/><td align="right" valign="bottom">3,900&#160;</td><td align="right" valign="bottom">244,140&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Vail Resorts, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">14,140&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">3,238,343&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">3,482,483&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Restaurants - 12.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ARAMARK Holdings Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">24,200&#160;</td><td align="right" valign="bottom">1,057,298&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Darden Restaurants, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">17,425&#160;</td><td align="right" valign="bottom">1,433,555&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Del Taco Restaurants, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">35,700&#160;</td><td align="right" valign="bottom">453,033&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Domino's Pizza, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">6,200&#160;</td><td align="right" valign="bottom">1,134,600&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Dunkin' Brands Group, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">12,900&#160;</td><td align="right" valign="bottom">762,003&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Jack in the Box, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">12,500&#160;</td><td align="right" valign="bottom">1,293,875&#160;</td>
</tr>
<tr>
<td align="left" valign="top">McDonald's Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">68,900&#160;</td><td align="right" valign="bottom">11,500,099&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Red Robin Gourmet Burgers, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">4,000&#160;</td><td align="right" valign="bottom">273,600&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Restaurant Brands International, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">22,900&#160;</td><td align="right" valign="bottom">1,479,509&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ruth's Hospitality Group, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">14,954&#160;</td><td align="right" valign="bottom">315,529&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Shake Shack, Inc. Class A (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">8,200&#160;</td><td align="right" valign="bottom">311,272&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Starbucks Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">177,776&#160;</td><td align="right" valign="bottom">9,749,236&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Texas Roadhouse, Inc. Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">15,400&#160;</td><td align="right" valign="bottom">770,154&#160;</td>
</tr>
<tr>
<td align="left" valign="top">U.S. Foods Holding Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">64,600&#160;</td><td align="right" valign="bottom">1,762,288&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Wingstop, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">21,800&#160;</td><td align="right" valign="bottom">738,366&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Yum! Brands, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">15,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,116,750&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">34,151,167&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL HOTELS, RESTAURANTS &amp; LEISURE&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">70,411,205&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Household Durables - 1.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Consumer Electronics - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Roku, Inc. Class A (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">2,400&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">48,912&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Home Furnishings - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Mohawk Industries, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,100&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">287,936&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Homebuilding - 1.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cavco Industries, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,500&#160;</td><td align="right" valign="bottom">235,350&#160;</td>
</tr>
<tr>
<td align="left" valign="top">D.R. Horton, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">35,300&#160;</td><td align="right" valign="bottom">1,560,613&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Lennar Corp. Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">19,800&#160;</td><td align="right" valign="bottom">1,102,266&#160;</td>
</tr>
<tr>
<td align="left" valign="top">LGI Homes, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">2,500&#160;</td><td align="right" valign="bottom">150,825&#160;</td>
</tr>
<tr>
<td align="left" valign="top">TRI Pointe Homes, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">29,400&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">520,086&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">3,569,140&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Household Appliances - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Techtronic Industries Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">70,500&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">413,435&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL HOUSEHOLD DURABLES&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">4,319,423&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Household Products - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Household Products - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Spectrum Brands Holdings, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,758&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">193,239&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet &amp; Direct Marketing Retail - 21.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet &amp; Direct Marketing Retail - 21.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Amazon.com, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">38,180&#160;</td><td align="right" valign="bottom">42,199,588&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Boohoo.Com PLC  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">124,200&#160;</td><td align="right" valign="bottom">330,737&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Liberty Interactive Corp. QVC Group Series A  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">68,069&#160;</td><td align="right" valign="bottom">1,546,528&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Netflix, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">36,383&#160;</td><td align="right" valign="bottom">7,146,713&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Priceline Group, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">2,900&#160;</td><td align="right" valign="bottom">5,544,684&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Wayfair LLC Class A (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,339&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">93,596&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">56,861,846&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet Software &amp; Services - 1.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet Software &amp; Services - 1.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">2U, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">5,200&#160;</td><td align="right" valign="bottom">330,876&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Alphabet, Inc. Class A (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,200&#160;</td><td align="right" valign="bottom">1,239,648&#160;</td>
</tr>
<tr>
<td align="left" valign="top">CarGurus, Inc. Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">400&#160;</td><td align="right" valign="bottom">13,040&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Facebook, Inc. Class A (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">5,600&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,008,336&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">2,591,900&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">IT Services - 0.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Data Processing &amp; Outsourced Services - 0.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Global Payments, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">4,000&#160;</td><td align="right" valign="bottom">415,800&#160;</td>
</tr>
<tr>
<td align="left" valign="top">PayPal Holdings, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">6,100&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">442,616&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">858,416&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Leisure Products - 0.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Leisure Products - 0.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Mattel, Inc.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">98,400&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,389,408&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Media - 14.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Cable &amp; Satellite - 9.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Charter Communications, Inc. Class A (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">41,994&#160;</td><td align="right" valign="bottom">14,033,135&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Comcast Corp. Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">269,300&#160;</td><td align="right" valign="bottom">9,702,879&#160;</td>
</tr>
<tr>
<td align="left" valign="top">DISH Network Corp. Class A (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">8,200&#160;</td><td align="right" valign="bottom">398,028&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Naspers Ltd. Class N&#160;</td><td valign="top"/><td align="right" valign="bottom">3,100&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">755,336&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">24,889,378&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Movies &amp; Entertainment - 5.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cinemark Holdings, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">22,700&#160;</td><td align="right" valign="bottom">824,918&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Liberty Media Corp. Liberty Formula One Group Series C  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">7,400&#160;</td><td align="right" valign="bottom">282,236&#160;</td>
</tr>
<tr>
<td align="left" valign="top">The Walt Disney Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">125,506&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">12,275,742&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">13,382,896&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL MEDIA&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">38,272,274&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Multiline Retail - 4.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">General Merchandise Stores - 4.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">B&amp;M European Value Retail S.A.&#160;</td><td valign="top"/><td align="right" valign="bottom">136,069&#160;</td><td align="right" valign="bottom">718,001&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Dollar General Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">9,900&#160;</td><td align="right" valign="bottom">800,316&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Dollar Tree, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">99,600&#160;</td><td align="right" valign="bottom">9,088,500&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ollie's Bargain Outlet Holdings, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">2,800&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">125,020&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">10,731,837&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Personal Products - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Personal Products - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Herbalife Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">4,200&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">305,004&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Real Estate Management &amp; Development - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Real Estate Services - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Redfin Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">500&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">11,770&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Software - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Home Entertainment Software - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Activision Blizzard, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">3,300&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">216,117&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Specialty Retail - 17.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Apparel Retail - 4.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Burlington Stores, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">20,000&#160;</td><td align="right" valign="bottom">1,877,800&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Inditex SA&#160;</td><td valign="top"/><td align="right" valign="bottom">11,861&#160;</td><td align="right" valign="bottom">443,434&#160;</td>
</tr>
<tr>
<td align="left" valign="top">L Brands, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">2,800&#160;</td><td align="right" valign="bottom">120,512&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ross Stores, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">75,969&#160;</td><td align="right" valign="bottom">4,823,272&#160;</td>
</tr>
<tr>
<td align="left" valign="top">The Children's Place Retail Stores, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">2,300&#160;</td><td align="right" valign="bottom">250,240&#160;</td>
</tr>
<tr>
<td align="left" valign="top">TJX Companies, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">65,211&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,551,728&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">12,066,986&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Automotive Retail - 2.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">AutoZone, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">4,200&#160;</td><td align="right" valign="bottom">2,475,900&#160;</td>
</tr>
<tr>
<td align="left" valign="top">O'Reilly Automotive, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">15,962&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">3,367,184&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">5,843,084&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Home Improvement Retail - 9.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Home Depot, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">145,820&#160;</td><td align="right" valign="bottom">24,174,040&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Lowe's Companies, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">24,500&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,958,775&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">26,132,815&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Specialty Stores - 0.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ulta Beauty, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">4,600&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">928,234&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL SPECIALTY RETAIL&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">44,971,119&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Technology Hardware, Storage &amp; Peripherals - 0.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Technology Hardware, Storage &amp; Peripherals - 0.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Apple, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">7,500&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,267,800&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Textiles, Apparel &amp; Luxury Goods - 5.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Apparel, Accessories &amp; Luxury Goods - 2.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">adidas AG&#160;</td><td valign="top"/><td align="right" valign="bottom">4,052&#160;</td><td align="right" valign="bottom">901,751&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Carter's, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">8,900&#160;</td><td align="right" valign="bottom">860,897&#160;</td>
</tr>
<tr>
<td align="left" valign="top">G-III Apparel Group Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">10,900&#160;</td><td align="right" valign="bottom">276,206&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Kering SA&#160;</td><td valign="top"/><td align="right" valign="bottom">600&#160;</td><td align="right" valign="bottom">275,021&#160;</td>
</tr>
<tr>
<td align="left" valign="top">LVMH Moet Hennessy - Louis Vuitton SA&#160;</td><td valign="top"/><td align="right" valign="bottom">2,831&#160;</td><td align="right" valign="bottom">844,384&#160;</td>
</tr>
<tr>
<td align="left" valign="top">PVH Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">19,000&#160;</td><td align="right" valign="bottom">2,409,390&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Tapestry, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">12,400&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">507,780&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">6,075,429&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Footwear - 3.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NIKE, Inc. Class B&#160;</td><td valign="top"/><td align="right" valign="bottom">164,034&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">9,020,230&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL TEXTILES, APPAREL &amp; LUXURY GOODS&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">15,095,659&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL COMMON STOCKS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $200,749,270)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">263,522,566&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Money Market Funds - 0.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund 1.11% (c)(d)&#160;</td><td valign="top"/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $1,622,131)&#160;</td><td/><td align="right" valign="top">1,621,969&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">1,622,131&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL INVESTMENT IN SECURITIES - 100.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">(Cost $202,371,401)&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td style="font-weight: bold;" align="right" valign="top">265,144,697&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET OTHER ASSETS (LIABILITIES) - (0.5)%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">(1,279,954)&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET ASSETS - 100%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: double 3px black; font-weight: bold;">$263,864,743&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 12pt Arial, Helvetica, sans-serif;">Legend</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(a)&#160;Non-income producing</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(b)&#160;Security or a portion of the security is on loan at period end.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(c)&#160;Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(d)&#160;Investment made with cash collateral received from securities on loan.</p>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Affiliated Central Funds</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Fund&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Income earned&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund&#160;</td><td align="right" valign="bottom">$2,008&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,440&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Total&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$6,448&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investment Valuation</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">The following is a summary of the inputs used, as of October 31, 2017, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. Additional information on valuation inputs, and their aggregation into the levels used below, is provided later in this section.</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td style="font-weight: bold;" align="center" valign="bottom" colspan="4">Valuation Inputs at Reporting Date:&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Description&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Total&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 1&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 2&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 3&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top"><u>Investments in Securities:</u>&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Common Stocks&#160;</td><td align="right" valign="bottom">$263,522,566&#160;</td><td align="right" valign="bottom">$262,678,182&#160;</td><td align="right" valign="bottom">$844,384&#160;</td><td align="right" valign="bottom">$--&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Money Market Funds&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,622,131&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,622,131&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td>
</tr>
<tr>
<td style="font-weight: bold" valign="top">Total Investments in Securities:&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$265,144,697&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$264,300,313&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$844,384&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$--&#160;</td>
</tr>
</table>
<br/>
<p>Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund&#146;s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:</p>
<p>Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. Utilizing these techniques may result in transfers between Level 1 and Level 2. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.</p>
<p>Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.</p>
<p>For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.</p>
<br/>
<br/>
<br/>
<br/>
<p style="font-style: italic;">
</p><p style="font-style: italic;">The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.</p>

<p style="font-style: italic;">
</p><p style="font-style: italic;">Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.</p>

<hr size="2" noshade="noshade"/>
</div>
<div style="font: normal 11pt Arial, Helvetica, sans-serif; width: 780px">
<!-- Automatically produced using the ProofPlus Content Management System -->
<p style="font: bold 18pt Arial, Helvetica, sans-serif; margin-bottom: 0px;" align="center">Quarterly Holdings Report<br clear="all"/>for</p>
<p style="font: bold 20pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">Fidelity Advisor&#174; Energy Fund</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">October 31, 2017</p>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>ANR-QTLY-1217<br/>1.809101.114<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<a name="">
<p style="font: bold 16pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investments October 31, 2017 (Unaudited)</p>
</a>
<p style="font: normal 11pt Arial, Helvetica, sans-serif; margin-top: 0px;">Showing Percentage of Net Assets</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="0" cellpadding="5" width="745">
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Common Stocks - 99.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td/><td style="font-weight: bold;" align="center" valign="bottom">Shares&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Value&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Chemicals - 2.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Commodity Chemicals - 2.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">LG Chemical Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">7,531&#160;</td><td align="right" valign="bottom">$2,717,812&#160;</td>
</tr>
<tr>
<td align="left" valign="top">LyondellBasell Industries NV Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">141,100&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">14,608,083&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">17,325,895&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electric Utilities - 1.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electric Utilities - 1.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NextEra Energy, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">54,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">8,373,780&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Energy Equipment &amp; Services - 13.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Oil &amp; Gas Drilling - 2.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Nabors Industries Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,001,700&#160;</td><td align="right" valign="bottom">5,639,571&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Odfjell Drilling A/S  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">564,256&#160;</td><td align="right" valign="bottom">2,258,958&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Shelf Drilling Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">865,700&#160;</td><td align="right" valign="bottom">6,889,141&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Trinidad Drilling Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">971,300&#160;</td><td align="right" valign="bottom">1,279,909&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Xtreme Drilling &amp; Coil Services Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,160,402&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,888,880&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">17,956,459&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Oil &amp; Gas Equipment &amp; Services - 11.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Baker Hughes, a GE Co. Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">277,200&#160;</td><td align="right" valign="bottom">8,712,396&#160;</td>
</tr>
<tr>
<td align="left" valign="top">C&amp;J Energy Services, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">51,000&#160;</td><td align="right" valign="bottom">1,452,990&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Dril-Quip, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">152,491&#160;</td><td align="right" valign="bottom">6,419,871&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Frank's International NV  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">407,745&#160;</td><td align="right" valign="bottom">2,695,194&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Halliburton Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">867,700&#160;</td><td align="right" valign="bottom">37,085,498&#160;</td>
</tr>
<tr>
<td align="left" valign="top">National Oilwell Varco, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">202,200&#160;</td><td align="right" valign="bottom">6,913,218&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NCS Multistage Holdings, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">222,900&#160;</td><td align="right" valign="bottom">4,854,762&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Newpark Resources, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">793,200&#160;</td><td align="right" valign="bottom">6,940,500&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Oceaneering International, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">216,273&#160;</td><td align="right" valign="bottom">4,373,040&#160;</td>
</tr>
<tr>
<td align="left" valign="top">RigNet, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">274,950&#160;</td><td align="right" valign="bottom">4,797,878&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Schlumberger Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">246,518&#160;</td><td align="right" valign="bottom">15,777,152&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Smart Sand, Inc.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">137,500&#160;</td><td align="right" valign="bottom">988,625&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Tesco Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">196,400&#160;</td><td align="right" valign="bottom">756,140&#160;</td>
</tr>
<tr>
<td align="left" valign="top">TETRA Technologies, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">510,500&#160;</td><td align="right" valign="bottom">1,449,820&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Total Energy Services, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">38,900&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">458,020&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">103,675,104&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL ENERGY EQUIPMENT &amp; SERVICES&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">121,631,563&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Gas Utilities - 0.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Gas Utilities - 0.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Indraprastha Gas Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">189,459&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,638,161&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Machinery - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Industrial Machinery - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ProPetro Holding Corp.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">130,700&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,990,561&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Oil, Gas &amp; Consumable Fuels - 82.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Integrated Oil &amp; Gas - 15.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Chevron Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">568,109&#160;</td><td align="right" valign="bottom">65,838,152&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Exxon Mobil Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">516,261&#160;</td><td align="right" valign="bottom">43,030,354&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Occidental Petroleum Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">227,000&#160;</td><td align="right" valign="bottom">14,657,390&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Suncor Energy, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">238,100&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">8,083,699&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">131,609,595&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Oil &amp; Gas Exploration &amp; Production - 52.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Anadarko Petroleum Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">187,783&#160;</td><td align="right" valign="bottom">9,270,847&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cabot Oil &amp; Gas Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">559,000&#160;</td><td align="right" valign="bottom">15,484,300&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Callon Petroleum Co.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,210,200&#160;</td><td align="right" valign="bottom">13,421,118&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Centennial Resource Development, Inc.:&#160;</td><td valign="top"/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">45,200&#160;</td><td align="right" valign="bottom">878,236&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Class A (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">385,500&#160;</td><td align="right" valign="bottom">7,490,265&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cimarex Energy Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">191,747&#160;</td><td align="right" valign="bottom">22,420,977&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Concho Resources, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">137,400&#160;</td><td align="right" valign="bottom">18,440,454&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ConocoPhillips Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">172,800&#160;</td><td align="right" valign="bottom">8,838,720&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Continental Resources, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">432,100&#160;</td><td align="right" valign="bottom">17,590,791&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Devon Energy Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">564,200&#160;</td><td align="right" valign="bottom">20,818,980&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Diamondback Energy, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">459,100&#160;</td><td align="right" valign="bottom">49,197,156&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Encana Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,553,300&#160;</td><td align="right" valign="bottom">18,168,589&#160;</td>
</tr>
<tr>
<td align="left" valign="top">EOG Resources, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">661,586&#160;</td><td align="right" valign="bottom">66,072,596&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Extraction Oil &amp; Gas, Inc.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">526,516&#160;</td><td align="right" valign="bottom">8,397,930&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Hess Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">117,000&#160;</td><td align="right" valign="bottom">5,166,720&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Jagged Peak Energy, Inc.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">70,600&#160;</td><td align="right" valign="bottom">980,634&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Lilis Energy, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">171,085&#160;</td><td align="right" valign="bottom">852,003&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Marathon Oil Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">222,300&#160;</td><td align="right" valign="bottom">3,161,106&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Matador Resources Co.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">268,300&#160;</td><td align="right" valign="bottom">7,123,365&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Murphy Oil Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">78,000&#160;</td><td align="right" valign="bottom">2,086,500&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Newfield Exploration Co.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">657,000&#160;</td><td align="right" valign="bottom">20,229,030&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Parsley Energy, Inc. Class A (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">978,700&#160;</td><td align="right" valign="bottom">26,033,420&#160;</td>
</tr>
<tr>
<td align="left" valign="top">PDC Energy, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">210,888&#160;</td><td align="right" valign="bottom">10,740,526&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Pioneer Natural Resources Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">322,916&#160;</td><td align="right" valign="bottom">48,330,838&#160;</td>
</tr>
<tr>
<td align="left" valign="top">PrairieSky Royalty Ltd.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">86,900&#160;</td><td align="right" valign="bottom">2,313,112&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Range Resources Corp.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">101,700&#160;</td><td align="right" valign="bottom">1,841,787&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Resolute Energy Corp.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">114,777&#160;</td><td align="right" valign="bottom">3,446,753&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ring Energy, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">264,032&#160;</td><td align="right" valign="bottom">3,382,250&#160;</td>
</tr>
<tr>
<td align="left" valign="top">RSP Permian, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">727,200&#160;</td><td align="right" valign="bottom">25,022,952&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Seven Generations Energy Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">505,100&#160;</td><td align="right" valign="bottom">7,626,810&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Viper Energy Partners LP&#160;</td><td valign="top"/><td align="right" valign="bottom">378,500&#160;</td><td align="right" valign="bottom">7,418,600&#160;</td>
</tr>
<tr>
<td align="left" valign="top">WPX Energy, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">820,800&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">9,258,624&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">461,505,989&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Oil &amp; Gas Refining &amp; Marketing - 6.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Andeavor&#160;</td><td valign="top"/><td align="right" valign="bottom">79,500&#160;</td><td align="right" valign="bottom">8,446,080&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Delek U.S. Holdings, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">667,300&#160;</td><td align="right" valign="bottom">17,383,165&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Phillips 66 Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">298,418&#160;</td><td align="right" valign="bottom">27,179,911&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Reliance Industries Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">412,346&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">5,991,594&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">59,000,750&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Oil &amp; Gas Storage &amp; Transport - 7.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cheniere Energy, Inc.(a)&#160;</td><td valign="top"/><td align="right" valign="bottom">165,700&#160;</td><td align="right" valign="bottom">7,744,818&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Enterprise Products Partners LP&#160;</td><td valign="top"/><td align="right" valign="bottom">388,200&#160;</td><td align="right" valign="bottom">9,510,900&#160;</td>
</tr>
<tr>
<td align="left" valign="top">GasLog Partners LP&#160;</td><td valign="top"/><td align="right" valign="bottom">117,100&#160;</td><td align="right" valign="bottom">2,781,125&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Gener8 Maritime, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,143,609&#160;</td><td align="right" valign="bottom">5,272,037&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Golar LNG Ltd. (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">196,500&#160;</td><td align="right" valign="bottom">4,152,045&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Noble Midstream Partners LP&#160;</td><td valign="top"/><td align="right" valign="bottom">130,287&#160;</td><td align="right" valign="bottom">6,756,684&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Noble Midstream Partners LP  (c)&#160;</td><td valign="top"/><td align="right" valign="bottom">48,372&#160;</td><td align="right" valign="bottom">2,508,572&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Plains GP Holdings LP Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">101,300&#160;</td><td align="right" valign="bottom">2,066,520&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Teekay LNG Partners LP&#160;</td><td valign="top"/><td align="right" valign="bottom">64,100&#160;</td><td align="right" valign="bottom">1,105,725&#160;</td>
</tr>
<tr>
<td align="left" valign="top">The Williams Companies, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">841,200&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">23,974,200&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">65,872,626&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL OIL, GAS &amp; CONSUMABLE FUELS&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">717,988,960&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL COMMON STOCKS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $800,173,832)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">871,948,920&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Money Market Funds - 5.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund, 1.10% (d)&#160;</td><td valign="top"/><td align="right" valign="bottom">4,165,296&#160;</td><td align="right" valign="bottom">4,166,129&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund 1.11% (d)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">45,361,713&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">45,366,249&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL MONEY MARKET FUNDS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $49,531,275)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">49,532,378&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL INVESTMENT IN SECURITIES - 105.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">(Cost $849,705,107)&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td style="font-weight: bold;" align="right" valign="top">921,481,298&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET OTHER ASSETS (LIABILITIES) - (5.3)%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">(46,659,023)&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET ASSETS - 100%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: double 3px black; font-weight: bold;">$874,822,275&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 12pt Arial, Helvetica, sans-serif;">Legend</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(a)&#160;Non-income producing</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(b)&#160;Security or a portion of the security is on loan at period end.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(c)&#160;Restricted securities - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues).  At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $2,508,572 or 0.3% of net assets.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(d)&#160;Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(e)&#160;Investment made with cash collateral received from securities on loan.</p>
<br/>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Additional information on each restricted holding is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Security&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Acquisition Date&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Acquisition Cost&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Noble Midstream Partners LP&#160;</td><td align="right" valign="bottom">6/21/17&#160;</td><td align="right" valign="bottom">$1,956,647&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Affiliated Central Funds</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Fund&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Income earned&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund&#160;</td><td align="right" valign="bottom">$12,304&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">40,315&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Total&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$52,619&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investment Valuation</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">All investments are categorized as Level 1 under the Fair Value Hierarchy. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. Additional information on valuation inputs is provided later in this section.</p>
<p>Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund&#146;s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:</p>
<p>Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. Utilizing these techniques may result in transfers between Level 1 and Level 2. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.</p>
<p>Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.</p>
<p>For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.</p>
<br/>
<br/>
<br/>
<br/>
<p style="font-style: italic;">
</p><p style="font-style: italic;">The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.</p>

<p style="font-style: italic;">
</p><p style="font-style: italic;">Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.</p>

<hr size="2" noshade="noshade"/>
</div>
<div style="font: normal 11pt Arial, Helvetica, sans-serif; width: 780px">
<!-- Automatically produced using the ProofPlus Content Management System -->
<p style="font: bold 18pt Arial, Helvetica, sans-serif; margin-bottom: 0px;" align="center">Quarterly Holdings Report<br clear="all"/>for</p>
<p style="font: bold 20pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">Fidelity Advisor&#174; Financial Services Fund</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">October 31, 2017</p>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>AFFS-QTLY-1217<br/>1.809094.114<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<a name="">
<p style="font: bold 16pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investments October 31, 2017 (Unaudited)</p>
</a>
<p style="font: normal 11pt Arial, Helvetica, sans-serif; margin-top: 0px;">Showing Percentage of Net Assets</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="0" cellpadding="5" width="745">
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Common Stocks - 98.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td/><td style="font-weight: bold;" align="center" valign="bottom">Shares&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Value&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Banks - 34.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Diversified Banks - 17.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Bank of America Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">791,656&#160;</td><td align="right" valign="bottom">$21,683,458&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Citigroup, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">318,915&#160;</td><td align="right" valign="bottom">23,440,253&#160;</td>
</tr>
<tr>
<td align="left" valign="top">HDFC Bank Ltd. sponsored ADR&#160;</td><td valign="top"/><td align="right" valign="bottom">5,200&#160;</td><td align="right" valign="bottom">479,960&#160;</td>
</tr>
<tr>
<td align="left" valign="top">JPMorgan Chase &amp; Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">143,331&#160;</td><td align="right" valign="bottom">14,420,532&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Wells Fargo &amp; Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">226,178&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">12,697,633&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">72,721,836&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Regional Banks - 17.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Bank of the Ozarks, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">92,900&#160;</td><td align="right" valign="bottom">4,330,998&#160;</td>
</tr>
<tr>
<td align="left" valign="top">CIT Group, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">52,800&#160;</td><td align="right" valign="bottom">2,461,536&#160;</td>
</tr>
<tr>
<td align="left" valign="top">CoBiz, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">137,191&#160;</td><td align="right" valign="bottom">2,804,184&#160;</td>
</tr>
<tr>
<td align="left" valign="top">East West Bancorp, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">60,600&#160;</td><td align="right" valign="bottom">3,626,304&#160;</td>
</tr>
<tr>
<td align="left" valign="top">First Republic Bank&#160;</td><td valign="top"/><td align="right" valign="bottom">36,600&#160;</td><td align="right" valign="bottom">3,564,840&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Huntington Bancshares, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,415,100&#160;</td><td align="right" valign="bottom">19,528,380&#160;</td>
</tr>
<tr>
<td align="left" valign="top">PNC Financial Services Group, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">103,800&#160;</td><td align="right" valign="bottom">14,198,802&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Popular, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">86,617&#160;</td><td align="right" valign="bottom">3,177,112&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Preferred Bank, Los Angeles&#160;</td><td valign="top"/><td align="right" valign="bottom">14,800&#160;</td><td align="right" valign="bottom">913,604&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Regions Financial Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">207,900&#160;</td><td align="right" valign="bottom">3,218,292&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Signature Bank  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">25,800&#160;</td><td align="right" valign="bottom">3,354,258&#160;</td>
</tr>
<tr>
<td align="left" valign="top">SunTrust Banks, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">114,900&#160;</td><td align="right" valign="bottom">6,918,129&#160;</td>
</tr>
<tr>
<td align="left" valign="top">SVB Financial Group  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">7,100&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,556,888&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">69,653,327&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL BANKS&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">142,375,163&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Capital Markets - 25.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Asset Management &amp; Custody Banks - 8.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Affiliated Managers Group, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">31,754&#160;</td><td align="right" valign="bottom">5,922,121&#160;</td>
</tr>
<tr>
<td align="left" valign="top">BlackRock, Inc. Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">18,500&#160;</td><td align="right" valign="bottom">8,710,355&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Invesco Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">208,700&#160;</td><td align="right" valign="bottom">7,469,373&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Northern Trust Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">105,500&#160;</td><td align="right" valign="bottom">9,866,360&#160;</td>
</tr>
<tr>
<td align="left" valign="top">State Street Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">22,500&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,070,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">34,038,209&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Financial Exchanges &amp; Data - 4.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">CBOE Holdings, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">83,473&#160;</td><td align="right" valign="bottom">9,437,457&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Deutsche Borse AG&#160;</td><td valign="top"/><td align="right" valign="bottom">13,900&#160;</td><td align="right" valign="bottom">1,439,553&#160;</td>
</tr>
<tr>
<td align="left" valign="top">IntercontinentalExchange, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">139,220&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">9,202,442&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">20,079,452&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Investment Banking &amp; Brokerage - 12.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">E*TRADE Financial Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">334,300&#160;</td><td align="right" valign="bottom">14,572,137&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Goldman Sachs Group, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">61,940&#160;</td><td align="right" valign="bottom">15,019,211&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Investment Technology Group, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">93,075&#160;</td><td align="right" valign="bottom">2,184,470&#160;</td>
</tr>
<tr>
<td align="left" valign="top">TD Ameritrade Holding Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">354,200&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">17,706,458&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">49,482,276&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL CAPITAL MARKETS&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">103,599,937&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Consumer Finance - 8.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Consumer Finance - 8.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Capital One Financial Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">252,338&#160;</td><td align="right" valign="bottom">23,260,517&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Synchrony Financial&#160;</td><td valign="top"/><td align="right" valign="bottom">330,200&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">10,771,124&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">34,031,641&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Diversified Financial Services - 4.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Multi-Sector Holdings - 4.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Berkshire Hathaway, Inc. Class B (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">106,259&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">19,864,057&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Insurance - 21.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Insurance Brokers - 1.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Willis Group Holdings PLC&#160;</td><td valign="top"/><td align="right" valign="bottom">34,600&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">5,573,368&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Life &amp; Health Insurance - 5.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">MetLife, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">228,700&#160;</td><td align="right" valign="bottom">12,253,746&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Torchmark Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">102,980&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">8,663,707&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">20,917,453&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Multi-Line Insurance - 2.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Hartford Financial Services Group, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">219,900&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">12,105,495&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Property &amp; Casualty Insurance - 10.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Allstate Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">86,590&#160;</td><td align="right" valign="bottom">8,127,337&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Chubb Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">97,427&#160;</td><td align="right" valign="bottom">14,693,940&#160;</td>
</tr>
<tr>
<td align="left" valign="top">FNF Group&#160;</td><td valign="top"/><td align="right" valign="bottom">147,550&#160;</td><td align="right" valign="bottom">5,521,321&#160;</td>
</tr>
<tr>
<td align="left" valign="top">The Travelers Companies, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">106,300&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">14,079,435&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">42,422,033&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Reinsurance - 1.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Reinsurance Group of America, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">50,100&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">7,483,938&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL INSURANCE&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">88,502,287&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">IT Services - 2.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Data Processing &amp; Outsourced Services - 2.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Visa, Inc. Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">38,120&#160;</td><td align="right" valign="bottom">4,192,438&#160;</td>
</tr>
<tr>
<td align="left" valign="top">WEX, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">55,900&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">6,908,681&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">11,101,119&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Software - 0.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Application Software - 0.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Black Knight, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">42,483&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,926,604&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Thrifts &amp; Mortgage Finance - 0.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Thrifts &amp; Mortgage Finance - 0.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">MGIC Investment Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">135,300&#160;</td><td align="right" valign="bottom">1,934,790&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Radian Group, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">42,600&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">892,896&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">2,827,686&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL COMMON STOCKS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $341,275,545)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">404,228,494&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Money Market Funds - 2.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund, 1.10% (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $8,007,158)&#160;</td><td/><td align="right" valign="top">8,005,557&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">8,007,158&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL INVESTMENT IN SECURITIES - 100.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">(Cost $349,282,703)&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td style="font-weight: bold;" align="right" valign="top">412,235,652&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET OTHER ASSETS (LIABILITIES) - (0.4)%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">(1,527,138)&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET ASSETS - 100%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: double 3px black; font-weight: bold;">$410,708,514&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 12pt Arial, Helvetica, sans-serif;">Legend</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(a)&#160;Non-income producing</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(b)&#160;Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.</p>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Affiliated Central Funds</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Fund&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Income earned&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund&#160;</td><td align="right" valign="bottom">$16,887&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">74&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Total&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$16,961&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investment Valuation</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">The following is a summary of the inputs used, as of October 31, 2017, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. Additional information on valuation inputs, and their aggregation into the levels used below, is provided later in this section.</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td style="font-weight: bold;" align="center" valign="bottom" colspan="4">Valuation Inputs at Reporting Date:&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Description&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Total&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 1&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 2&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 3&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top"><u>Investments in Securities:</u>&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Common Stocks&#160;</td><td align="right" valign="bottom">$404,228,494&#160;</td><td align="right" valign="bottom">$402,788,941&#160;</td><td align="right" valign="bottom">$1,439,553&#160;</td><td align="right" valign="bottom">$--&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Money Market Funds&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">8,007,158&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">8,007,158&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td>
</tr>
<tr>
<td style="font-weight: bold" valign="top">Total Investments in Securities:&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$412,235,652&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$410,796,099&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$1,439,553&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$--&#160;</td>
</tr>
</table>
<br/>
<p>Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund&#146;s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:</p>
<p>Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. Utilizing these techniques may result in transfers between Level 1 and Level 2. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.</p>
<p>Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.</p>
<p>For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.</p>
<br/>
<br/>
<br/>
<br/>
<p style="font-style: italic;">
</p><p style="font-style: italic;">The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.</p>

<p style="font-style: italic;">
</p><p style="font-style: italic;">Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.</p>

<hr size="2" noshade="noshade"/>
</div>
<div style="font: normal 11pt Arial, Helvetica, sans-serif; width: 780px">
<!-- Automatically produced using the ProofPlus Content Management System -->
<p style="font: bold 18pt Arial, Helvetica, sans-serif; margin-bottom: 0px;" align="center">Quarterly Holdings Report<br clear="all"/>for</p>
<p style="font: bold 20pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">Fidelity Advisor&#174; Global Real Estate Fund</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">October 31, 2017</p>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>AGRE-QTLY-1217<br/>1.9879813.101<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<a name="">
<p style="font: bold 16pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investments October 31, 2017 (Unaudited)</p>
</a>
<p style="font: normal 11pt Arial, Helvetica, sans-serif; margin-top: 0px;">Showing Percentage of Net Assets</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="0" cellpadding="5" width="745">
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Common Stocks - 96.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td/><td style="font-weight: bold;" align="center" valign="bottom">Shares&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Value&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Australia - 5.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Abacus Property Group unit&#160;</td><td valign="top"/><td align="right" valign="bottom">6,665&#160;</td><td align="right" valign="bottom">$19,384&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Goodman Group unit&#160;</td><td valign="top"/><td align="right" valign="bottom">4,800&#160;</td><td align="right" valign="bottom">30,712&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ingenia Communities Group unit&#160;</td><td valign="top"/><td align="right" valign="bottom">14,604&#160;</td><td align="right" valign="bottom">29,620&#160;</td>
</tr>
<tr>
<td align="left" valign="top">National Storage (REIT) unit&#160;</td><td valign="top"/><td align="right" valign="bottom">19,455&#160;</td><td align="right" valign="bottom">21,963&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Propertylink Group unit&#160;</td><td valign="top"/><td align="right" valign="bottom">25,400&#160;</td><td align="right" valign="bottom">19,440&#160;</td>
</tr>
<tr>
<td align="left" valign="top">The GPT Group unit&#160;</td><td valign="top"/><td align="right" valign="bottom">7,560&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">29,451&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL AUSTRALIA&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">150,570&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Austria - 2.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">BUWOG-Gemeinnuetzige Wohnung&#160;</td><td valign="top"/><td align="right" valign="bottom">1,892&#160;</td><td align="right" valign="bottom">54,568&#160;</td>
</tr>
<tr>
<td align="left" valign="top">CA Immobilien Anlagen AG&#160;</td><td valign="top"/><td align="right" valign="bottom">560&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">15,982&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL AUSTRIA&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">70,550&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Bermuda - 1.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Hongkong Land Holdings Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">6,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">43,500&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Canada - 0.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Smart (REIT)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,074&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">24,126&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">France - 3.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Accor SA&#160;</td><td valign="top"/><td align="right" valign="bottom">380&#160;</td><td align="right" valign="bottom">18,961&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Gecina SA&#160;</td><td valign="top"/><td align="right" valign="bottom">176&#160;</td><td align="right" valign="bottom">28,558&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Unibail-Rodamco&#160;</td><td valign="top"/><td align="right" valign="bottom">245&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">61,316&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL FRANCE&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">108,835&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Germany - 3.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">LEG Immobilien AG&#160;</td><td valign="top"/><td align="right" valign="bottom">551&#160;</td><td align="right" valign="bottom">55,968&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Vonovia SE&#160;</td><td valign="top"/><td align="right" valign="bottom">1,230&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">54,101&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL GERMANY&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">110,069&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Hong Kong - 2.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sino Land Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">13,700&#160;</td><td align="right" valign="bottom">23,602&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sun Hung Kai Properties Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">3,600&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">58,882&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL HONG KONG&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">82,484&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Ireland - 2.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Hibernia (REIT) PLC&#160;</td><td valign="top"/><td align="right" valign="bottom">33,100&#160;</td><td align="right" valign="bottom">56,871&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Irish Residential Properties REIT PLC&#160;</td><td valign="top"/><td align="right" valign="bottom">14,700&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">25,257&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL IRELAND&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">82,128&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Italy - 0.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">COIMA RES SpA&#160;</td><td valign="top"/><td align="right" valign="bottom">1,700&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">17,129&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Japan - 10.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Advance Residence Investment Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">12&#160;</td><td align="right" valign="bottom">28,209&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ichigo, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">7,400&#160;</td><td align="right" valign="bottom">26,316&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Japan Senior Living Investment Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">10&#160;</td><td align="right" valign="bottom">12,197&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Kenedix Office Investment Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">6&#160;</td><td align="right" valign="bottom">32,144&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Mitsubishi Estate Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">2,240&#160;</td><td align="right" valign="bottom">40,621&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Mitsui Fudosan Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">3,960&#160;</td><td align="right" valign="bottom">92,430&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NTT Urban Development Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">2,100&#160;</td><td align="right" valign="bottom">21,737&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ORIX JREIT, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">22&#160;</td><td align="right" valign="bottom">30,228&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Star Asia Investment Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">13&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">11,906&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL JAPAN&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">295,788&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Luxembourg - 0.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Aroundtown Property Holdings PLC&#160;</td><td valign="top"/><td align="right" valign="bottom">2,629&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">18,466&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Mexico - 0.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Concentradora Fibra Hotelera Mexicana SA de CV&#160;</td><td valign="top"/><td align="right" valign="bottom">13,000&#160;</td><td align="right" valign="bottom">8,707&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Terrafina&#160;</td><td valign="top"/><td align="right" valign="bottom">4,600&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">7,081&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL MEXICO&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">15,788&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Singapore - 4.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Mapletree Commercial Trust&#160;</td><td valign="top"/><td align="right" valign="bottom">23,200&#160;</td><td align="right" valign="bottom">26,466&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Parkway Life REIT&#160;</td><td valign="top"/><td align="right" valign="bottom">21,800&#160;</td><td align="right" valign="bottom">45,580&#160;</td>
</tr>
<tr>
<td align="left" valign="top">UOL Group Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">6,800&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">45,097&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL SINGAPORE&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">117,143&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Spain - 0.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Aedas Homes SAU&#160;</td><td valign="top"/><td align="right" valign="bottom">134&#160;</td><td align="right" valign="bottom">4,683&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Hispania Activos Inmobiliarios SA&#160;</td><td valign="top"/><td align="right" valign="bottom">385&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">6,640&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL SPAIN&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">11,323&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Sweden - 0.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Castellum AB&#160;</td><td valign="top"/><td align="right" valign="bottom">400&#160;</td><td align="right" valign="bottom">6,417&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Victoria Park AB&#160;</td><td valign="top"/><td align="right" valign="bottom">2,900&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">10,704&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL SWEDEN&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">17,121&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">United Kingdom - 6.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">British Land Co. PLC&#160;</td><td valign="top"/><td align="right" valign="bottom">6,970&#160;</td><td align="right" valign="bottom">55,636&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Derwent London PLC&#160;</td><td valign="top"/><td align="right" valign="bottom">1,029&#160;</td><td align="right" valign="bottom">36,572&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Londonmetric Properity PLC&#160;</td><td valign="top"/><td align="right" valign="bottom">15,195&#160;</td><td align="right" valign="bottom">35,600&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Tritax Big Box REIT PLC&#160;</td><td valign="top"/><td align="right" valign="bottom">14,175&#160;</td><td align="right" valign="bottom">27,731&#160;</td>
</tr>
<tr>
<td align="left" valign="top">U &amp; I Group PLC&#160;</td><td valign="top"/><td align="right" valign="bottom">7,753&#160;</td><td align="right" valign="bottom">18,998&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Workspace Group PLC&#160;</td><td valign="top"/><td align="right" valign="bottom">910&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">10,696&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL UNITED KINGDOM&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">185,233&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">United States of America - 48.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">American Homes 4 Rent Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">1,251&#160;</td><td align="right" valign="bottom">26,621&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Apartment Investment &amp; Management Co. Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">699&#160;</td><td align="right" valign="bottom">30,742&#160;</td>
</tr>
<tr>
<td align="left" valign="top">AvalonBay Communities, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">293&#160;</td><td align="right" valign="bottom">53,130&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Boston Properties, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">566&#160;</td><td align="right" valign="bottom">68,588&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Brandywine Realty Trust (SBI)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,606&#160;</td><td align="right" valign="bottom">28,089&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Brixmor Property Group, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,027&#160;</td><td align="right" valign="bottom">17,942&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Camden Property Trust (SBI)&#160;</td><td valign="top"/><td align="right" valign="bottom">189&#160;</td><td align="right" valign="bottom">17,244&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cousins Properties, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,725&#160;</td><td align="right" valign="bottom">15,560&#160;</td>
</tr>
<tr>
<td align="left" valign="top">DCT Industrial Trust, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">903&#160;</td><td align="right" valign="bottom">52,392&#160;</td>
</tr>
<tr>
<td align="left" valign="top">DiamondRock Hospitality Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,655&#160;</td><td align="right" valign="bottom">17,973&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Digital Realty Trust, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">425&#160;</td><td align="right" valign="bottom">50,337&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Duke Realty Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">2,566&#160;</td><td align="right" valign="bottom">73,080&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Equity Lifestyle Properties, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">659&#160;</td><td align="right" valign="bottom">58,308&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Equity Residential (SBI)&#160;</td><td valign="top"/><td align="right" valign="bottom">436&#160;</td><td align="right" valign="bottom">29,325&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Essex Property Trust, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">122&#160;</td><td align="right" valign="bottom">32,016&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Extra Space Storage, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">495&#160;</td><td align="right" valign="bottom">40,387&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Gaming &amp; Leisure Properties&#160;</td><td valign="top"/><td align="right" valign="bottom">580&#160;</td><td align="right" valign="bottom">21,193&#160;</td>
</tr>
<tr>
<td align="left" valign="top">General Growth Properties, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">2,109&#160;</td><td align="right" valign="bottom">41,041&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Gramercy Property Trust&#160;</td><td valign="top"/><td align="right" valign="bottom">1,103&#160;</td><td align="right" valign="bottom">32,759&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Host Hotels &amp; Resorts, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,840&#160;</td><td align="right" valign="bottom">35,990&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Hudson Pacific Properties, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">702&#160;</td><td align="right" valign="bottom">23,742&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Kimco Realty Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,155&#160;</td><td align="right" valign="bottom">20,975&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Prologis, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,632&#160;</td><td align="right" valign="bottom">105,394&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Public Storage&#160;</td><td valign="top"/><td align="right" valign="bottom">260&#160;</td><td align="right" valign="bottom">53,885&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Regency Centers Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">359&#160;</td><td align="right" valign="bottom">22,096&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Simon Property Group, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">490&#160;</td><td align="right" valign="bottom">76,112&#160;</td>
</tr>
<tr>
<td align="left" valign="top">SL Green Realty Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">284&#160;</td><td align="right" valign="bottom">27,173&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Spirit Realty Capital, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,700&#160;</td><td align="right" valign="bottom">14,127&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sun Communities, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">415&#160;</td><td align="right" valign="bottom">37,458&#160;</td>
</tr>
<tr>
<td align="left" valign="top">UDR, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">2,094&#160;</td><td align="right" valign="bottom">81,226&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ventas, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,160&#160;</td><td align="right" valign="bottom">72,790&#160;</td>
</tr>
<tr>
<td align="left" valign="top">VEREIT, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">5,292&#160;</td><td align="right" valign="bottom">41,754&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Welltower, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">811&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">54,305&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL UNITED STATES OF AMERICA&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">1,373,754&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL COMMON STOCKS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $2,679,983)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">2,724,007&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Money Market Funds - 4.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund, 1.10% (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $114,055)&#160;</td><td/><td align="right" valign="top">114,033&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">114,055&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL INVESTMENT IN SECURITIES - 100.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">(Cost $2,794,038)&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td style="font-weight: bold;" align="right" valign="top">2,838,062&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET OTHER ASSETS (LIABILITIES) - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">(571)&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET ASSETS - 100%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: double 3px black; font-weight: bold;">$2,837,491&#160;</td>
</tr>
</table>
<br/>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Categorizations in the Schedule of Investments are based on country or territory of incorporation.</p>
<p style="font: bold 12pt Arial, Helvetica, sans-serif;">Legend</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(a)&#160;Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.</p>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Affiliated Central Funds</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Fund&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Income earned&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">$287&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Total&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$287&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investment Valuation</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">The following is a summary of the inputs used, as of October 31, 2017, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. Additional information on valuation inputs, and their aggregation into the levels used below, is provided later in this section.</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td style="font-weight: bold;" align="center" valign="bottom" colspan="4">Valuation Inputs at Reporting Date:&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Description&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Total&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 1&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 2&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 3&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top"><u>Investments in Securities:</u>&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Equities:&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:30px; text-indent:-10px; ">Consumer Discretionary&#160;</td><td align="right" valign="bottom">$18,961&#160;</td><td align="right" valign="bottom">$18,961&#160;</td><td align="right" valign="bottom">$--&#160;</td><td align="right" valign="bottom">$--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:30px; text-indent:-10px; ">Financials&#160;</td><td align="right" valign="bottom">31,346&#160;</td><td align="right" valign="bottom">19,440&#160;</td><td align="right" valign="bottom">11,906&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:30px; text-indent:-10px; ">Real Estate&#160;</td><td align="right" valign="bottom">2,673,700&#160;</td><td align="right" valign="bottom">2,389,818&#160;</td><td align="right" valign="bottom">283,882&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Money Market Funds&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">114,055&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">114,055&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td>
</tr>
<tr>
<td style="font-weight: bold" valign="top">Total Investments in Securities:&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$2,838,062&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$2,542,274&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$295,788&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$--&#160;</td>
</tr>
</table>
<br/>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">The following is a summary of transfers between Level 1 and Level 2 for the period ended October 31, 2017. Transfers are assumed to have occurred at the beginning of the period, and are primarily attributable to the valuation techniques used for foreign equity securities, as discussed at the end of this section:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Transfers&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Total&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Level 1 to Level 2&#160;</td><td align="right" valign="bottom">$280,652&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Level 2 to Level 1&#160;</td><td align="right" valign="bottom">$0&#160;</td>
</tr>
</table>
<br/>
<p>Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund&#146;s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:</p>
<p>Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. Utilizing these techniques may result in transfers between Level 1 and Level 2. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.</p>
<p>Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.</p>
<p>For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.</p>
<br/>
<br/>
<br/>
<br/>
<p style="font-style: italic;">
</p><p style="font-style: italic;">The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.</p>

<p style="font-style: italic;">
</p><p style="font-style: italic;">Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.</p>

<hr size="2" noshade="noshade"/>
</div>
<div style="font: normal 11pt Arial, Helvetica, sans-serif; width: 780px">
<!-- Automatically produced using the ProofPlus Content Management System -->
<p style="font: bold 18pt Arial, Helvetica, sans-serif; margin-bottom: 0px;" align="center">Quarterly Holdings Report<br clear="all"/>for</p>
<p style="font: bold 20pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">Fidelity Advisor&#174; Health Care Fund</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">October 31, 2017</p>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>AFHC-QTLY-1217<br/>1.809075.114<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<a name="">
<p style="font: bold 16pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investments October 31, 2017 (Unaudited)</p>
</a>
<p style="font: normal 11pt Arial, Helvetica, sans-serif; margin-top: 0px;">Showing Percentage of Net Assets</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="0" cellpadding="5" width="745">
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Common Stocks - 96.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td/><td style="font-weight: bold;" align="center" valign="bottom">Shares&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Value&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Biotechnology - 29.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Biotechnology - 29.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Abeona Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">400,000&#160;</td><td align="right" valign="bottom">$7,180,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ablynx NV  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">870,000&#160;</td><td align="right" valign="bottom">17,831,116&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ablynx NV sponsored ADR&#160;</td><td valign="top"/><td align="right" valign="bottom">83,200&#160;</td><td align="right" valign="bottom">1,730,560&#160;</td>
</tr>
<tr>
<td align="left" valign="top">AC Immune SA  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">390,500&#160;</td><td align="right" valign="bottom">4,592,280&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Acceleron Pharma, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">240,000&#160;</td><td align="right" valign="bottom">9,360,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Acorda Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">549,900&#160;</td><td align="right" valign="bottom">14,613,593&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Alexion Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">380,000&#160;</td><td align="right" valign="bottom">45,470,800&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Alnylam Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">201,491&#160;</td><td align="right" valign="bottom">24,549,663&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Amgen, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,280,000&#160;</td><td align="right" valign="bottom">224,281,600&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Amicus Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">720,000&#160;</td><td align="right" valign="bottom">10,252,800&#160;</td>
</tr>
<tr>
<td align="left" valign="top">AnaptysBio, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">253,600&#160;</td><td align="right" valign="bottom">16,745,208&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ascendis Pharma A/S sponsored ADR  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">400,000&#160;</td><td align="right" valign="bottom">13,592,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Audentes Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">242,100&#160;</td><td align="right" valign="bottom">6,437,439&#160;</td>
</tr>
<tr>
<td align="left" valign="top">BeiGene Ltd. ADR  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">128,859&#160;</td><td align="right" valign="bottom">11,893,686&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Biogen, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">244,000&#160;</td><td align="right" valign="bottom">76,045,040&#160;</td>
</tr>
<tr>
<td align="left" valign="top">BioMarin Pharmaceutical, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">260,000&#160;</td><td align="right" valign="bottom">21,343,400&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Bioverativ, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">52,300&#160;</td><td align="right" valign="bottom">2,954,950&#160;</td>
</tr>
<tr>
<td align="left" valign="top">bluebird bio, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">81,745&#160;</td><td align="right" valign="bottom">11,370,730&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Blueprint Medicines Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">355,000&#160;</td><td align="right" valign="bottom">23,579,100&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Calithera Biosciences, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">280,000&#160;</td><td align="right" valign="bottom">4,508,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cellectis SA sponsored ADR  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">227,000&#160;</td><td align="right" valign="bottom">7,947,270&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Curis, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,000,000&#160;</td><td align="right" valign="bottom">1,580,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cytokinetics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">305,600&#160;</td><td align="right" valign="bottom">4,171,440&#160;</td>
</tr>
<tr>
<td align="left" valign="top">CytomX Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">151,900&#160;</td><td align="right" valign="bottom">3,038,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Epizyme, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">350,000&#160;</td><td align="right" valign="bottom">5,845,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Five Prime Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">146,839&#160;</td><td align="right" valign="bottom">6,587,198&#160;</td>
</tr>
<tr>
<td align="left" valign="top">GlycoMimetics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">323,600&#160;</td><td align="right" valign="bottom">3,721,400&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Heron Therapeutics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">229,358&#160;</td><td align="right" valign="bottom">3,520,645&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Insmed, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,025,500&#160;</td><td align="right" valign="bottom">27,698,755&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Intercept Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">82,244&#160;</td><td align="right" valign="bottom">5,068,698&#160;</td>
</tr>
<tr>
<td align="left" valign="top">La Jolla Pharmaceutical Co.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">124,081&#160;</td><td align="right" valign="bottom">4,263,423&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Loxo Oncology, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">200,000&#160;</td><td align="right" valign="bottom">17,232,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Neurocrine Biosciences, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">367,158&#160;</td><td align="right" valign="bottom">22,804,183&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Prothena Corp. PLC  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">18,100&#160;</td><td align="right" valign="bottom">1,050,705&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Puma Biotechnology, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">130,000&#160;</td><td align="right" valign="bottom">16,549,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Regeneron Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">28,000&#160;</td><td align="right" valign="bottom">11,273,360&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Spark Therapeutics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">161,274&#160;</td><td align="right" valign="bottom">13,047,067&#160;</td>
</tr>
<tr>
<td align="left" valign="top">TESARO, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">260,000&#160;</td><td align="right" valign="bottom">30,100,200&#160;</td>
</tr>
<tr>
<td align="left" valign="top">uniQure B.V. (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">185,682&#160;</td><td align="right" valign="bottom">2,766,662&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Vertex Pharmaceuticals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">360,000&#160;</td><td align="right" valign="bottom">52,642,800&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Xencor, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">439,900&#160;</td><td align="right" valign="bottom">8,701,222&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Zai Lab Ltd. ADR&#160;</td><td valign="top"/><td align="right" valign="bottom">207,400&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">5,601,874&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">803,542,867&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Diversified Consumer Services - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Specialized Consumer Services - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Carriage Services, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">195,535&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">5,064,357&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Diversified Financial Services - 0.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Other Diversified Financial Services - 0.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">RPI International Holdings LP  (a)(c)(d)&#160;</td><td valign="top"/><td align="right" valign="bottom">61,683&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">8,421,272&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Food &amp; Staples Retailing - 2.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Drug Retail - 2.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">CVS Health Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">880,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">60,306,400&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Equipment &amp; Supplies - 22.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Equipment - 22.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Atricure, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">650,000&#160;</td><td align="right" valign="bottom">13,936,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Becton, Dickinson &amp; Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">707,220&#160;</td><td align="right" valign="bottom">147,575,597&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Boston Scientific Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">5,020,000&#160;</td><td align="right" valign="bottom">141,262,800&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Danaher Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">320,000&#160;</td><td align="right" valign="bottom">29,526,400&#160;</td>
</tr>
<tr>
<td align="left" valign="top">DexCom, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">540,000&#160;</td><td align="right" valign="bottom">24,283,800&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fisher &amp; Paykel Healthcare Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">900,000&#160;</td><td align="right" valign="bottom">8,160,278&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Insulet Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">480,000&#160;</td><td align="right" valign="bottom">28,228,800&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Integra LifeSciences Holdings Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">550,000&#160;</td><td align="right" valign="bottom">25,729,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Intuitive Surgical, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">234,000&#160;</td><td align="right" valign="bottom">87,834,240&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Medtronic PLC&#160;</td><td valign="top"/><td align="right" valign="bottom">372,000&#160;</td><td align="right" valign="bottom">29,953,440&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Penumbra, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">331,900&#160;</td><td align="right" valign="bottom">33,372,545&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Wright Medical Group NV  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,120,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">29,355,200&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">599,218,100&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Providers &amp; Services - 19.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Distributors &amp; Services - 0.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Amplifon SpA&#160;</td><td valign="top"/><td align="right" valign="bottom">660,000&#160;</td><td align="right" valign="bottom">10,025,165&#160;</td>
</tr>
<tr>
<td align="left" valign="top">EBOS Group Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,280,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">15,415,910&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">25,441,075&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Facilities - 2.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">HCA Holdings, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">330,000&#160;</td><td align="right" valign="bottom">24,964,500&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Universal Health Services, Inc. Class B&#160;</td><td valign="top"/><td align="right" valign="bottom">280,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">28,756,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">53,720,500&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Services - 2.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">American Renal Associates Holdings, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">130,000&#160;</td><td align="right" valign="bottom">1,576,900&#160;</td>
</tr>
<tr>
<td align="left" valign="top">G1 Therapeutics, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">30,391&#160;</td><td align="right" valign="bottom">718,139&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Premier, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">280,000&#160;</td><td align="right" valign="bottom">9,147,600&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Teladoc, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,040,000&#160;</td><td align="right" valign="bottom">34,372,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">United Drug PLC (United Kingdom)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,100,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">13,506,621&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">59,321,260&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Managed Health Care - 14.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Aetna, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">50,000&#160;</td><td align="right" valign="bottom">8,501,500&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cigna Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">565,000&#160;</td><td align="right" valign="bottom">111,429,300&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Humana, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">230,000&#160;</td><td align="right" valign="bottom">58,730,500&#160;</td>
</tr>
<tr>
<td align="left" valign="top">UnitedHealth Group, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,020,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">214,424,400&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">393,085,700&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL HEALTH CARE PROVIDERS &amp; SERVICES&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">531,568,535&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Technology - 4.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Technology - 4.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">athenahealth, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">190,000&#160;</td><td align="right" valign="bottom">24,297,200&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Castlight Health, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">336,800&#160;</td><td align="right" valign="bottom">1,296,680&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Castlight Health, Inc. Class B (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">407,600&#160;</td><td align="right" valign="bottom">1,569,260&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cerner Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,000,000&#160;</td><td align="right" valign="bottom">67,520,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Evolent Health, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">750,000&#160;</td><td align="right" valign="bottom">12,187,500&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Medidata Solutions, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">170,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">12,789,100&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">119,659,740&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet Software &amp; Services - 0.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet Software &amp; Services - 0.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Benefitfocus, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">700,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">19,180,000&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Life Sciences Tools &amp; Services - 1.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Life Sciences Tools &amp; Services - 1.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Agilent Technologies, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">350,000&#160;</td><td align="right" valign="bottom">23,810,500&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Lonza Group AG&#160;</td><td valign="top"/><td align="right" valign="bottom">30,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">7,968,727&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">31,779,227&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Pharmaceuticals - 15.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Pharmaceuticals - 15.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Allergan PLC&#160;</td><td valign="top"/><td align="right" valign="bottom">600,000&#160;</td><td align="right" valign="bottom">106,338,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Astellas Pharma, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,000,000&#160;</td><td align="right" valign="bottom">13,308,857&#160;</td>
</tr>
<tr>
<td align="left" valign="top">AstraZeneca PLC (United Kingdom)&#160;</td><td valign="top"/><td align="right" valign="bottom">640,000&#160;</td><td align="right" valign="bottom">43,303,017&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Avexis, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">25,641&#160;</td><td align="right" valign="bottom">2,679,741&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Bristol-Myers Squibb Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">800,000&#160;</td><td align="right" valign="bottom">49,328,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Dechra Pharmaceuticals PLC&#160;</td><td valign="top"/><td align="right" valign="bottom">800,000&#160;</td><td align="right" valign="bottom">21,845,411&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Eisai Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">220,000&#160;</td><td align="right" valign="bottom">12,244,461&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Indivior PLC  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">2,100,000&#160;</td><td align="right" valign="bottom">10,364,351&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Jazz Pharmaceuticals PLC  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">190,000&#160;</td><td align="right" valign="bottom">26,890,700&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Jiangsu Hengrui Medicine Co. Ltd. (A Shares)&#160;</td><td valign="top"/><td align="right" valign="bottom">2,160,000&#160;</td><td align="right" valign="bottom">21,886,811&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Mallinckrodt PLC  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">487,600&#160;</td><td align="right" valign="bottom">15,442,292&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Mylan N.V.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">280,000&#160;</td><td align="right" valign="bottom">9,998,800&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sanofi SA&#160;</td><td valign="top"/><td align="right" valign="bottom">330,000&#160;</td><td align="right" valign="bottom">31,246,595&#160;</td>
</tr>
<tr>
<td align="left" valign="top">The Medicines Company  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">403,700&#160;</td><td align="right" valign="bottom">11,602,338&#160;</td>
</tr>
<tr>
<td align="left" valign="top">TherapeuticsMD, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">2,700,000&#160;</td><td align="right" valign="bottom">12,744,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Theravance Biopharma, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">516,100&#160;</td><td align="right" valign="bottom">14,894,646&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Tonghua Dongbao Pharmaceutical Co. Ltd. Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">2,399,894&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">7,820,119&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">411,938,139&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL COMMON STOCKS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $2,015,920,227)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">2,590,678,637&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Preferred Stocks - 1.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Convertible Preferred Stocks - 0.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Providers &amp; Services - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Health Care Services - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">1Life Healthcare, Inc. Series G  (a)(c)(d)&#160;</td><td valign="top"/><td align="right" valign="bottom">322,145&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,261,458&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Software - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Application Software - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Outset Medical, Inc. Series C  (c)(d)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,003,280&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,600,000&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Textiles, Apparel &amp; Luxury Goods - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Textiles - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Harmony Biosciences II, Inc. Series A  (c)(d)&#160;</td><td valign="top"/><td align="right" valign="bottom">4,262,580&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,262,580&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL CONVERTIBLE PREFERRED STOCKS&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">9,124,038&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Nonconvertible Preferred Stocks - 0.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Equipment &amp; Supplies - 0.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Health Care Equipment - 0.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sartorius AG (non-vtg.)&#160;</td><td valign="top"/><td align="right" valign="bottom">190,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">17,707,933&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL PREFERRED STOCKS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $23,368,856)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">26,831,971&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Money Market Funds - 5.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund, 1.10% (e)&#160;</td><td valign="top"/><td align="right" valign="bottom">86,428,233&#160;</td><td align="right" valign="bottom">86,445,519&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund 1.11% (e)(f)&#160;</td><td valign="top"/><td align="right" valign="bottom">72,599,779&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">72,607,039&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL MONEY MARKET FUNDS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $159,048,910)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">159,052,558&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL INVESTMENT IN SECURITIES - 102.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">(Cost $2,198,337,993)&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td style="font-weight: bold;" align="right" valign="top">2,776,563,166&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET OTHER ASSETS (LIABILITIES) - (2.9)%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">(77,404,069)&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET ASSETS - 100%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: double 3px black; font-weight: bold;">$2,699,159,097&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 12pt Arial, Helvetica, sans-serif;">Legend</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(a)&#160;Non-income producing</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(b)&#160;Security or a portion of the security is on loan at period end.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(c)&#160;Restricted securities - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues).  At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $17,545,310 or 0.7% of net assets.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(d)&#160;Level 3 security</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(e)&#160;Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(f)&#160;Investment made with cash collateral received from securities on loan.</p>
<br/>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Additional information on each restricted holding is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Security&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Acquisition Date&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Acquisition Cost&#160;</td>
</tr>
<tr>
<td align="left" valign="top">1Life Healthcare, Inc. Series G&#160;</td><td align="right" valign="bottom">4/10/14&#160;</td><td align="right" valign="bottom">$2,121,583&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Harmony Biosciences II, Inc. Series A&#160;</td><td align="right" valign="bottom">9/22/17&#160;</td><td align="right" valign="bottom">$4,262,580&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Outset Medical, Inc. Series C&#160;</td><td align="right" valign="bottom">4/19/17&#160;</td><td align="right" valign="bottom">$2,600,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">RPI International Holdings LP&#160;</td><td align="right" valign="bottom">5/21/15 - 3/23/16&#160;</td><td align="right" valign="bottom">$8,207,868&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Affiliated Central Funds</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Fund&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Income earned&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund&#160;</td><td align="right" valign="bottom">$193,494&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">141,184&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Total&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$334,678&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investment Valuation</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">The following is a summary of the inputs used, as of October 31, 2017, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. Additional information on valuation inputs, and their aggregation into the levels used below, is provided later in this section.</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td style="font-weight: bold;" align="center" valign="bottom" colspan="4">Valuation Inputs at Reporting Date:&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Description&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Total&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 1&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 2&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 3&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top"><u>Investments in Securities:</u>&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Common Stocks&#160;</td><td align="right" valign="bottom">$2,590,678,637&#160;</td><td align="right" valign="bottom">$2,482,154,435&#160;</td><td align="right" valign="bottom">$100,102,930&#160;</td><td align="right" valign="bottom">$8,421,272&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Preferred Stocks&#160;</td><td align="right" valign="bottom">26,831,971&#160;</td><td align="right" valign="bottom">17,707,933&#160;</td><td align="right" valign="bottom">--&#160;</td><td align="right" valign="bottom">9,124,038&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Money Market Funds&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">159,052,558&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">159,052,558&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td>
</tr>
<tr>
<td style="font-weight: bold" valign="top">Total Investments in Securities:&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$2,776,563,166&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$2,658,914,926&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$100,102,930&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$17,545,310&#160;</td>
</tr>
</table>
<br/>
<p>Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund&#146;s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:</p>
<p>Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. Utilizing these techniques may result in transfers between Level 1 and Level 2. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.</p>
<p>Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.</p>
<p>For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.</p>
<br/>
<br/>
<br/>
<br/>
<p style="font-style: italic;">
</p><p style="font-style: italic;">The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.</p>

<p style="font-style: italic;">
</p><p style="font-style: italic;">Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.</p>

<hr size="2" noshade="noshade"/>
</div>
<div style="font: normal 11pt Arial, Helvetica, sans-serif; width: 780px">
<!-- Automatically produced using the ProofPlus Content Management System -->
<p style="font: bold 18pt Arial, Helvetica, sans-serif; margin-bottom: 0px;" align="center">Quarterly Holdings Report<br clear="all"/>for</p>
<p style="font: bold 20pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">Fidelity Advisor&#174; Industrials Fund</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">October 31, 2017</p>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>AFCY-QTLY-1217<br/>1.809093.114<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<a name="">
<p style="font: bold 16pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investments October 31, 2017 (Unaudited)</p>
</a>
<p style="font: normal 11pt Arial, Helvetica, sans-serif; margin-top: 0px;">Showing Percentage of Net Assets</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="0" cellpadding="5" width="745">
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Common Stocks - 99.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td/><td style="font-weight: bold;" align="center" valign="bottom">Shares&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Value&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Aerospace &amp; Defense - 26.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Aerospace &amp; Defense - 26.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Astronics Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">94,566&#160;</td><td align="right" valign="bottom">$3,253,070&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Astronics Corp. Class B&#160;</td><td valign="top"/><td align="right" valign="bottom">6,099&#160;</td><td align="right" valign="bottom">217,429&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Axon Enterprise, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">178,500&#160;</td><td align="right" valign="bottom">4,100,145&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Elbit Systems Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">27,000&#160;</td><td align="right" valign="bottom">4,012,740&#160;</td>
</tr>
<tr>
<td align="left" valign="top">General Dynamics Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">166,562&#160;</td><td align="right" valign="bottom">33,808,755&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Huntington Ingalls Industries, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">32,100&#160;</td><td align="right" valign="bottom">7,473,843&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Northrop Grumman Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">134,000&#160;</td><td align="right" valign="bottom">39,601,020&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Raytheon Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">151,100&#160;</td><td align="right" valign="bottom">27,228,220&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Rockwell Collins, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">53,200&#160;</td><td align="right" valign="bottom">7,213,920&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Teledyne Technologies, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">89,865&#160;</td><td align="right" valign="bottom">15,273,455&#160;</td>
</tr>
<tr>
<td align="left" valign="top">The Boeing Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">64,400&#160;</td><td align="right" valign="bottom">16,613,912&#160;</td>
</tr>
<tr>
<td align="left" valign="top">TransDigm Group, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">45,900&#160;</td><td align="right" valign="bottom">12,737,250&#160;</td>
</tr>
<tr>
<td align="left" valign="top">United Technologies Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">401,051&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">48,029,868&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">219,563,627&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Air Freight &amp; Logistics - 1.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Air Freight &amp; Logistics - 1.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">XPO Logistics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">169,300&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">11,740,955&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Airlines - 2.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Airlines - 2.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Allegiant Travel Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">800&#160;</td><td align="right" valign="bottom">109,120&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Delta Air Lines, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">78,900&#160;</td><td align="right" valign="bottom">3,947,367&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ryanair Holdings PLC sponsored ADR  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">27,200&#160;</td><td align="right" valign="bottom">3,049,392&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Southwest Airlines Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">295,700&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">15,926,402&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">23,032,281&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Building Products - 3.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Building Products - 3.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">A.O. Smith Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">181,584&#160;</td><td align="right" valign="bottom">10,749,773&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fortune Brands Home &amp; Security, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">140,000&#160;</td><td align="right" valign="bottom">9,248,400&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Masco Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">273,900&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">10,906,698&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">30,904,871&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Commercial Services &amp; Supplies - 4.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Diversified Support Services - 2.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cintas Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">88,000&#160;</td><td align="right" valign="bottom">13,115,520&#160;</td>
</tr>
<tr>
<td align="left" valign="top">KAR Auction Services, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">234,600&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">11,103,618&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">24,219,138&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Environmental &amp; Facility Services - 1.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Waste Connection, Inc. (United States)&#160;</td><td valign="top"/><td align="right" valign="bottom">140,600&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">9,936,202&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL COMMERCIAL SERVICES &amp; SUPPLIES&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">34,155,340&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Construction &amp; Engineering - 4.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Construction &amp; Engineering - 4.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">AECOM  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">540,721&#160;</td><td align="right" valign="bottom">18,957,678&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Dycom Industries, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">59,700&#160;</td><td align="right" valign="bottom">5,243,451&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fluor Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">70,500&#160;</td><td align="right" valign="bottom">3,037,845&#160;</td>
</tr>
<tr>
<td align="left" valign="top">KBR, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">549,200&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">10,780,796&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">38,019,770&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electrical Equipment - 7.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electrical Components &amp; Equipment - 6.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">AMETEK, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">254,526&#160;</td><td align="right" valign="bottom">17,177,960&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Eaton Corp. PLC&#160;</td><td valign="top"/><td align="right" valign="bottom">183,300&#160;</td><td align="right" valign="bottom">14,667,666&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fortive Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">324,866&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">23,474,817&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">55,320,443&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Heavy Electrical Equipment - 0.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">TPI Composites, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">161,900&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,055,595&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL ELECTRICAL EQUIPMENT&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">59,376,038&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Industrial Conglomerates - 9.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Industrial Conglomerates - 9.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">3M Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">9,200&#160;</td><td align="right" valign="bottom">2,117,748&#160;</td>
</tr>
<tr>
<td align="left" valign="top">General Electric Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,453,248&#160;</td><td align="right" valign="bottom">29,297,480&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Honeywell International, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">296,433&#160;</td><td align="right" valign="bottom">42,733,781&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ITT, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">115,300&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">5,377,592&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">79,526,601&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Machinery - 24.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Agricultural &amp; Farm Machinery - 1.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Deere &amp; Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">72,200&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">9,593,936&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Construction Machinery &amp; Heavy Trucks - 11.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Allison Transmission Holdings, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">432,500&#160;</td><td align="right" valign="bottom">18,376,925&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Caterpillar, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">355,100&#160;</td><td align="right" valign="bottom">48,222,581&#160;</td>
</tr>
<tr>
<td align="left" valign="top">PACCAR, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">58,600&#160;</td><td align="right" valign="bottom">4,203,378&#160;</td>
</tr>
<tr>
<td align="left" valign="top">WABCO Holdings, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">118,600&#160;</td><td align="right" valign="bottom">17,501,802&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Wabtec Corp.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">83,100&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">6,357,150&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">94,661,836&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Industrial Machinery - 12.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Flowserve Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">143,300&#160;</td><td align="right" valign="bottom">6,315,231&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Gardner Denver Holdings, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">180,000&#160;</td><td align="right" valign="bottom">5,193,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">IDEX Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">90,529&#160;</td><td align="right" valign="bottom">11,606,723&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ingersoll-Rand PLC&#160;</td><td valign="top"/><td align="right" valign="bottom">189,100&#160;</td><td align="right" valign="bottom">16,754,260&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Lincoln Electric Holdings, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">62,400&#160;</td><td align="right" valign="bottom">5,720,208&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Nordson Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">47,100&#160;</td><td align="right" valign="bottom">5,967,099&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Parker Hannifin Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">76,500&#160;</td><td align="right" valign="bottom">13,969,665&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Pentair PLC&#160;</td><td valign="top"/><td align="right" valign="bottom">107,318&#160;</td><td align="right" valign="bottom">7,561,626&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Rexnord Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">193,300&#160;</td><td align="right" valign="bottom">4,933,016&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Snap-On, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">126,200&#160;</td><td align="right" valign="bottom">19,911,836&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Xylem, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">85,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">5,655,050&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">103,587,714&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL MACHINERY&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">207,843,486&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Professional Services - 2.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Human Resource &amp; Employment Services - 0.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Robert Half International, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">124,400&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">6,440,188&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Research &amp; Consulting Services - 1.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Equifax, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">20,700&#160;</td><td align="right" valign="bottom">2,246,571&#160;</td>
</tr>
<tr>
<td align="left" valign="top">IHS Markit Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">289,500&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">12,335,595&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">14,582,166&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL PROFESSIONAL SERVICES&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">21,022,354&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Road &amp; Rail - 9.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Railroads - 7.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Genesee &amp; Wyoming, Inc. Class A (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">78,400&#160;</td><td align="right" valign="bottom">5,627,552&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Norfolk Southern Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">155,800&#160;</td><td align="right" valign="bottom">20,475,236&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Union Pacific Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">319,300&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">36,971,747&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">63,074,535&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Trucking - 1.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">J.B. Hunt Transport Services, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">61,684&#160;</td><td align="right" valign="bottom">6,562,561&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Old Dominion Freight Lines, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">54,700&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">6,625,811&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">13,188,372&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL ROAD &amp; RAIL&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">76,262,907&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Trading Companies &amp; Distributors - 2.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Trading Companies &amp; Distributors - 2.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">HD Supply Holdings, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">65,506&#160;</td><td align="right" valign="bottom">2,318,257&#160;</td>
</tr>
<tr>
<td align="left" valign="top">MSC Industrial Direct Co., Inc. Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">41,800&#160;</td><td align="right" valign="bottom">3,465,220&#160;</td>
</tr>
<tr>
<td align="left" valign="top">United Rentals, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">29,000&#160;</td><td align="right" valign="bottom">4,102,920&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Univar, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">437,800&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">13,024,550&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">22,910,947&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Water Utilities - 0.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Water Utilities - 0.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">AquaVenture Holdings Ltd.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">347,526&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,229,391&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL COMMON STOCKS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $629,047,947)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">828,588,568&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Money Market Funds - 1.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund, 1.10% (c)&#160;</td><td valign="top"/><td align="right" valign="bottom">5,428,689&#160;</td><td align="right" valign="bottom">5,429,775&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund 1.11% (c)(d)&#160;</td><td valign="top"/><td align="right" valign="bottom">6,944,152&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">6,944,846&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL MONEY MARKET FUNDS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $12,374,904)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">12,374,621&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL INVESTMENT IN SECURITIES - 100.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">(Cost $641,422,851)&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td style="font-weight: bold;" align="right" valign="top">840,963,189&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET OTHER ASSETS (LIABILITIES) - (0.9)%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">(7,665,646)&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET ASSETS - 100%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: double 3px black; font-weight: bold;">$833,297,543&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 12pt Arial, Helvetica, sans-serif;">Legend</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(a)&#160;Non-income producing</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(b)&#160;Security or a portion of the security is on loan at period end.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(c)&#160;Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(d)&#160;Investment made with cash collateral received from securities on loan.</p>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Affiliated Central Funds</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Fund&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Income earned&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund&#160;</td><td align="right" valign="bottom">$24,525&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">6,219&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Total&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$30,744&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investment Valuation</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">All investments are categorized as Level 1 under the Fair Value Hierarchy. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. Additional information on valuation inputs is provided later in this section.</p>
<p>Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund&#146;s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:</p>
<p>Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. Utilizing these techniques may result in transfers between Level 1 and Level 2. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.</p>
<p>Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.</p>
<p>For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.</p>
<br/>
<br/>
<br/>
<br/>
<p style="font-style: italic;">
</p><p style="font-style: italic;">The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.</p>

<p style="font-style: italic;">
</p><p style="font-style: italic;">Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.</p>

<hr size="2" noshade="noshade"/>
</div>
<div style="font: normal 11pt Arial, Helvetica, sans-serif; width: 780px">
<!-- Automatically produced using the ProofPlus Content Management System -->
<p style="font: bold 18pt Arial, Helvetica, sans-serif; margin-bottom: 0px;" align="center">Quarterly Holdings Report<br clear="all"/>for</p>
<p style="font: bold 20pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">Fidelity Advisor&#174; Real Estate Fund</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">October 31, 2017</p>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>ARE-QTLY-1217<br/>1.809102.114<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<a name="">
<p style="font: bold 16pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investments October 31, 2017 (Unaudited)</p>
</a>
<p style="font: normal 11pt Arial, Helvetica, sans-serif; margin-top: 0px;">Showing Percentage of Net Assets</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="0" cellpadding="5" width="745">
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Common Stocks - 99.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td/><td style="font-weight: bold;" align="center" valign="bottom">Shares&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Value&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Equity Real Estate Investment Trusts (REITs) - 97.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">REITs - Apartments - 19.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">American Homes 4 Rent Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">816,800&#160;</td><td align="right" valign="bottom">$17,381,504&#160;</td>
</tr>
<tr>
<td align="left" valign="top">AvalonBay Communities, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">267,740&#160;</td><td align="right" valign="bottom">48,549,294&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Education Realty Trust, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">319,300&#160;</td><td align="right" valign="bottom">11,143,570&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Equity Residential (SBI)&#160;</td><td valign="top"/><td align="right" valign="bottom">283,609&#160;</td><td align="right" valign="bottom">19,075,541&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Essex Property Trust, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">139,647&#160;</td><td align="right" valign="bottom">36,647,562&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Mid-America Apartment Communities, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">268,849&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">27,516,695&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">160,314,166&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">REITs - Diversified - 8.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Corrections Corp. of America&#160;</td><td valign="top"/><td align="right" valign="bottom">122,300&#160;</td><td align="right" valign="bottom">3,015,918&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Digital Realty Trust, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">87,900&#160;</td><td align="right" valign="bottom">10,410,876&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Duke Realty Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">765,100&#160;</td><td align="right" valign="bottom">21,790,048&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Equinix, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">43,400&#160;</td><td align="right" valign="bottom">20,115,900&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Washington REIT (SBI)&#160;</td><td valign="top"/><td align="right" valign="bottom">475,200&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">15,296,688&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">70,629,430&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">REITs - Health Care - 10.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Healthcare Realty Trust, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">494,300&#160;</td><td align="right" valign="bottom">15,936,232&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sabra Health Care REIT, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">154,961&#160;</td><td align="right" valign="bottom">3,086,823&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ventas, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">638,905&#160;</td><td align="right" valign="bottom">40,091,289&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Welltower, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">374,119&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">25,051,008&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">84,165,352&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">REITs - Hotels - 6.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">DiamondRock Hospitality Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,166,450&#160;</td><td align="right" valign="bottom">12,667,647&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Host Hotels &amp; Resorts, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">866,334&#160;</td><td align="right" valign="bottom">16,945,493&#160;</td>
</tr>
<tr>
<td align="left" valign="top">LaSalle Hotel Properties (SBI)&#160;</td><td valign="top"/><td align="right" valign="bottom">225,000&#160;</td><td align="right" valign="bottom">6,347,250&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sunstone Hotel Investors, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,032,800&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">16,855,296&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">52,815,686&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">REITs - Management/Investment - 1.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">American Assets Trust, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">178,500&#160;</td><td align="right" valign="bottom">6,924,015&#160;</td>
</tr>
<tr>
<td align="left" valign="top">American Tower Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">17,500&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,514,225&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">9,438,240&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">REITs - Manufactured Homes - 2.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Equity Lifestyle Properties, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">252,703&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">22,359,161&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">REITs - Office Property - 17.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Boston Properties, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">315,047&#160;</td><td align="right" valign="bottom">38,177,395&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Corporate Office Properties Trust (SBI)&#160;</td><td valign="top"/><td align="right" valign="bottom">412,300&#160;</td><td align="right" valign="bottom">13,164,739&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Douglas Emmett, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">586,900&#160;</td><td align="right" valign="bottom">23,352,751&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Highwoods Properties, Inc. (SBI)&#160;</td><td valign="top"/><td align="right" valign="bottom">414,400&#160;</td><td align="right" valign="bottom">21,155,120&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Hudson Pacific Properties, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">594,400&#160;</td><td align="right" valign="bottom">20,102,608&#160;</td>
</tr>
<tr>
<td align="left" valign="top">SL Green Realty Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">253,900&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">24,293,152&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">140,245,765&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">REITs - Regional Malls - 9.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">General Growth Properties, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,289,000&#160;</td><td align="right" valign="bottom">25,083,940&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Simon Property Group, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">297,850&#160;</td><td align="right" valign="bottom">46,265,041&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Taubman Centers, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">146,600&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">6,922,452&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">78,271,433&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">REITs - Shopping Centers - 5.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Acadia Realty Trust (SBI)&#160;</td><td valign="top"/><td align="right" valign="bottom">223,900&#160;</td><td align="right" valign="bottom">6,302,785&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cedar Realty Trust, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,117,570&#160;</td><td align="right" valign="bottom">6,079,581&#160;</td>
</tr>
<tr>
<td align="left" valign="top">DDR Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">896,600&#160;</td><td align="right" valign="bottom">6,876,922&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Urban Edge Properties&#160;</td><td valign="top"/><td align="right" valign="bottom">889,641&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">20,870,978&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">40,130,266&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">REITs - Storage - 8.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Extra Space Storage, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">396,600&#160;</td><td align="right" valign="bottom">32,358,594&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Public Storage&#160;</td><td valign="top"/><td align="right" valign="bottom">161,350&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">33,439,788&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">65,798,382&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">REITs - Warehouse/Industrial - 7.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">DCT Industrial Trust, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">462,066&#160;</td><td align="right" valign="bottom">26,809,069&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Prologis, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">399,077&#160;</td><td align="right" valign="bottom">25,772,393&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Rexford Industrial Realty, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">180,600&#160;</td><td align="right" valign="bottom">5,362,014&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Terreno Realty Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">75,680&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,778,970&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">60,722,446&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Specialized REITs - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Safety Income and Growth, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">111,500&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,003,655&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL EQUITY REAL ESTATE INVESTMENT TRUSTS (REITS)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">786,893,982&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Hotels, Restaurants &amp; Leisure - 1.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Hotels, Resorts &amp; Cruise Lines - 1.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Marriott International, Inc. Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">77,500&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">9,259,700&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Real Estate Management &amp; Development - 0.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Real Estate Operating Companie - 0.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Vonovia SE&#160;</td><td valign="top"/><td align="right" valign="bottom">98,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,310,504&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL COMMON STOCKS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $657,031,786)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">800,464,186&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Money Market Funds - 0.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund, 1.10% (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $5,828,544)&#160;</td><td/><td align="right" valign="top">5,827,379&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">5,828,544&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL INVESTMENT IN SECURITIES - 99.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">(Cost $662,860,330)&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td style="font-weight: bold;" align="right" valign="top">806,292,730&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET OTHER ASSETS (LIABILITIES) - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">1,251,387&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET ASSETS - 100%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: double 3px black; font-weight: bold;">$807,544,117&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 12pt Arial, Helvetica, sans-serif;">Legend</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(a)&#160;Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.</p>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Affiliated Central Funds</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Fund&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Income earned&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund&#160;</td><td align="right" valign="bottom">$28,030&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">411&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Total&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$28,441&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investment Valuation</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">All investments are categorized as Level 1 under the Fair Value Hierarchy. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. Additional information on valuation inputs is provided later in this section.</p>
<p>Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events, changes in interest rates and credit quality. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund&#146;s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:</p>
<p>Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. Utilizing these techniques may result in transfers between Level 1 and Level 2. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.</p>
<p>Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.</p>
<p>For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.</p>
<br/>
<br/>
<br/>
<br/>
<p style="font-style: italic;">
</p><p style="font-style: italic;">The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.</p>

<p style="font-style: italic;">
</p><p style="font-style: italic;">Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.</p>

<hr size="2" noshade="noshade"/>
</div>
<div style="font: normal 11pt Arial, Helvetica, sans-serif; width: 780px">
<!-- Automatically produced using the ProofPlus Content Management System -->
<p style="font: bold 18pt Arial, Helvetica, sans-serif; margin-bottom: 0px;" align="center">Quarterly Holdings Report<br clear="all"/>for</p>
<p style="font: bold 20pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">Fidelity Advisor&#174; Semiconductors Fund</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">October 31, 2017</p>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>AFEL-QTLY-1217<br/>1.809067.114<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<a name="">
<p style="font: bold 16pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investments October 31, 2017 (Unaudited)</p>
</a>
<p style="font: normal 11pt Arial, Helvetica, sans-serif; margin-top: 0px;">Showing Percentage of Net Assets</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="0" cellpadding="5" width="745">
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Common Stocks - 94.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td/><td style="font-weight: bold;" align="center" valign="bottom">Shares&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Value&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Communications Equipment - 2.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Communications Equipment - 2.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Brocade Communications Systems, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">196,900&#160;</td><td align="right" valign="bottom">$2,293,885&#160;</td>
</tr>
<tr>
<td align="left" valign="top">CommScope Holding Co., Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">38,100&#160;</td><td align="right" valign="bottom">1,224,534&#160;</td>
</tr>
<tr>
<td align="left" valign="top">F5 Networks, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">5,500&#160;</td><td align="right" valign="bottom">666,985&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Finisar Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">21,800&#160;</td><td align="right" valign="bottom">513,172&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Infinera Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">49,600&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">415,152&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">5,113,728&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Diversified Financial Services - 0.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Other Diversified Financial Services - 0.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Quantenna Communications, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">69,644&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,078,786&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electronic Equipment &amp; Components - 4.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electronic Manufacturing Services - 2.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Flextronics International Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">78,800&#160;</td><td align="right" valign="bottom">1,402,640&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Jabil, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">69,576&#160;</td><td align="right" valign="bottom">1,967,609&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Park Electrochemical Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">13,000&#160;</td><td align="right" valign="bottom">245,440&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Plexus Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">12,000&#160;</td><td align="right" valign="bottom">737,160&#160;</td>
</tr>
<tr>
<td align="left" valign="top">TTM Technologies, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">91,600&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,445,448&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">5,798,297&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Technology Distributors - 2.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Avnet, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">118,400&#160;</td><td align="right" valign="bottom">4,712,320&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Tech Data Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">9,500&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">881,315&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">5,593,635&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL ELECTRONIC EQUIPMENT &amp; COMPONENTS&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">11,391,932&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet Software &amp; Services - 2.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet Software &amp; Services - 2.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Akamai Technologies, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">34,200&#160;</td><td align="right" valign="bottom">1,786,950&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Alphabet, Inc. Class A (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">5,510&#160;</td><td align="right" valign="bottom">5,692,050&#160;</td>
</tr>
<tr>
<td align="left" valign="top">SecureWorks Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">5,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">50,100&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">7,529,100&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">IT Services - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">IT Consulting &amp; Other Services - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">IBM Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">2,300&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">354,338&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Semiconductors &amp; Semiconductor Equipment - 82.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Semiconductor Equipment - 2.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Applied Materials, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">31,700&#160;</td><td align="right" valign="bottom">1,788,831&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Experi Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">26,600&#160;</td><td align="right" valign="bottom">611,800&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Lam Research Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">5,281&#160;</td><td align="right" valign="bottom">1,101,458&#160;</td>
</tr>
<tr>
<td align="left" valign="top">PDF Solutions, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">60,795&#160;</td><td align="right" valign="bottom">890,647&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Xcerra Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">89,664&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">883,190&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">5,275,926&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Semiconductors - 80.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Acacia Communications, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">34,500&#160;</td><td align="right" valign="bottom">1,459,695&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Advanced Micro Devices, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">12,000&#160;</td><td align="right" valign="bottom">131,820&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Alpha &amp; Omega Semiconductor Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">25,400&#160;</td><td align="right" valign="bottom">468,122&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ambarella, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">7,500&#160;</td><td align="right" valign="bottom">423,300&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Analog Devices, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">162,470&#160;</td><td align="right" valign="bottom">14,833,511&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Broadcom Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">96,900&#160;</td><td align="right" valign="bottom">25,572,879&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cavium, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">80,091&#160;</td><td align="right" valign="bottom">5,525,478&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cirrus Logic, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">11,700&#160;</td><td align="right" valign="bottom">655,200&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cree, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">80,900&#160;</td><td align="right" valign="bottom">2,888,130&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cypress Semiconductor Corp.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">347,100&#160;</td><td align="right" valign="bottom">5,505,006&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Inphi Corp.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">130,338&#160;</td><td align="right" valign="bottom">5,341,251&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Integrated Device Technology, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">73,800&#160;</td><td align="right" valign="bottom">2,292,966&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Intel Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">866,375&#160;</td><td align="right" valign="bottom">39,411,399&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Lattice Semiconductor Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">264,700&#160;</td><td align="right" valign="bottom">1,548,495&#160;</td>
</tr>
<tr>
<td align="left" valign="top">M/A-COM Technology Solutions Holdings, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">26,200&#160;</td><td align="right" valign="bottom">1,071,056&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Marvell Technology Group Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">293,600&#160;</td><td align="right" valign="bottom">5,422,792&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Maxim Integrated Products, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">100,522&#160;</td><td align="right" valign="bottom">5,281,426&#160;</td>
</tr>
<tr>
<td align="left" valign="top">MaxLinear, Inc. Class A (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">132,647&#160;</td><td align="right" valign="bottom">3,245,872&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Mellanox Technologies Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">69,000&#160;</td><td align="right" valign="bottom">3,225,750&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Microchip Technology, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">35,600&#160;</td><td align="right" valign="bottom">3,374,880&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Micron Technology, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">403,412&#160;</td><td align="right" valign="bottom">17,875,186&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Microsemi Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">22,800&#160;</td><td align="right" valign="bottom">1,216,836&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NVIDIA Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">60,323&#160;</td><td align="right" valign="bottom">12,475,400&#160;</td>
</tr>
<tr>
<td align="left" valign="top">O2Micro International Ltd. sponsored ADR  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">8,600&#160;</td><td align="right" valign="bottom">17,114&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ON Semiconductor Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">433,900&#160;</td><td align="right" valign="bottom">9,250,748&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Qorvo, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">43,396&#160;</td><td align="right" valign="bottom">3,289,851&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Qualcomm, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">554,626&#160;</td><td align="right" valign="bottom">28,291,472&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sanken Electric Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">112,000&#160;</td><td align="right" valign="bottom">704,269&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Semtech Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">103,622&#160;</td><td align="right" valign="bottom">4,253,683&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sequans Communications SA ADR  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">52,900&#160;</td><td align="right" valign="bottom">95,749&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Synaptics, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">22,200&#160;</td><td align="right" valign="bottom">824,064&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Texas Instruments, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">24,300&#160;</td><td align="right" valign="bottom">2,349,567&#160;</td>
</tr>
<tr>
<td align="left" valign="top">United Microelectronics Corp. sponsored ADR  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">157,200&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">408,720&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">208,731,687&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL SEMICONDUCTORS &amp; SEMICONDUCTOR EQUIPMENT&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">214,007,613&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Software - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Application Software - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Citrix Systems, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">6,100&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">503,921&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Technology Hardware, Storage &amp; Peripherals - 1.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Technology Hardware, Storage &amp; Peripherals - 1.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Lenovo Group Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">862,000&#160;</td><td align="right" valign="bottom">499,428&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Samsung Electronics Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">525&#160;</td><td align="right" valign="bottom">1,293,143&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Super Micro Computer, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">27,900&#160;</td><td align="right" valign="bottom">555,210&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Western Digital Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">16,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,428,320&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">3,776,101&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL COMMON STOCKS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $187,781,958)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">243,755,519&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td/><td style="font-weight: bold;" align="center" valign="bottom">Principal Amount&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Value&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Convertible Bonds - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Semiconductors &amp; Semiconductor Equipment - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Semiconductors - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Synaptics, Inc. 0.5% 6/15/22 (c)&#160;</td><td valign="top"/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">    (Cost $317,283)&#160;</td><td/><td align="right" valign="bottom">350,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;"> 314,563&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td/><td style="font-weight: bold;" align="center" valign="bottom">Shares&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Value&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Money Market Funds - 7.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund, 1.10% (d)&#160;</td><td valign="top"/><td align="right" valign="bottom">13,251,928&#160;</td><td align="right" valign="bottom">13,254,579&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund 1.11% (d)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">4,656,562&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,657,028&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL MONEY MARKET FUNDS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $17,911,223)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">17,911,607&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL INVESTMENT IN SECURITIES - 101.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">(Cost $206,010,464)&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td style="font-weight: bold;" align="right" valign="top">261,981,689&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET OTHER ASSETS (LIABILITIES) - (1.5)%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">(3,823,469)&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET ASSETS - 100%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: double 3px black; font-weight: bold;">$258,158,220&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 12pt Arial, Helvetica, sans-serif;">Legend</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(a)&#160;Non-income producing</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(b)&#160;Security or a portion of the security is on loan at period end.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(c)&#160;Security exempt from registration under Rule 144A of the Securities Act of 1933.  These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $314,563 or 0.1% of net assets.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(d)&#160;Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(e)&#160;Investment made with cash collateral received from securities on loan.</p>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Affiliated Central Funds</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Fund&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Income earned&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund&#160;</td><td align="right" valign="bottom">$27,198&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">55,574&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Total&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$82,772&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investment Valuation</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">The following is a summary of the inputs used, as of October 31, 2017, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. Additional information on valuation inputs, and their aggregation into the levels used below, is provided later in this section.</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td style="font-weight: bold;" align="center" valign="bottom" colspan="4">Valuation Inputs at Reporting Date:&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Description&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Total&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 1&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 2&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 3&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top"><u>Investments in Securities:</u>&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Common Stocks&#160;</td><td align="right" valign="bottom">$243,755,519&#160;</td><td align="right" valign="bottom">$243,051,250&#160;</td><td align="right" valign="bottom">$704,269&#160;</td><td align="right" valign="bottom">$--&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Convertible Bonds&#160;</td><td align="right" valign="bottom">314,563&#160;</td><td align="right" valign="bottom">--&#160;</td><td align="right" valign="bottom">314,563&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Money Market Funds&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">17,911,607&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">17,911,607&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td>
</tr>
<tr>
<td style="font-weight: bold" valign="top">Total Investments in Securities:&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$261,981,689&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$260,962,857&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$1,018,832&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$--&#160;</td>
</tr>
</table>
<br/>
<p>Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund&#146;s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:</p>
<p>Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. Utilizing these techniques may result in transfers between Level 1 and Level 2. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.</p>
<p>Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.</p>
<p>For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.</p>
<br/>
<br/>
<br/>
<br/>
<p style="font-style: italic;">
</p><p style="font-style: italic;">The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.</p>

<p style="font-style: italic;">
</p><p style="font-style: italic;">Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.</p>

<hr size="2" noshade="noshade"/>
</div>
<div style="font: normal 11pt Arial, Helvetica, sans-serif; width: 780px">
<!-- Automatically produced using the ProofPlus Content Management System -->
<p style="font: bold 18pt Arial, Helvetica, sans-serif; margin-bottom: 0px;" align="center">Quarterly Holdings Report<br clear="all"/>for</p>
<p style="font: bold 20pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">Fidelity Advisor&#174; Technology Fund</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">October 31, 2017</p>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>AFTF-QTLY-1217<br/>1.809103.114<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<a name="">
<p style="font: bold 16pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investments October 31, 2017 (Unaudited)</p>
</a>
<p style="font: normal 11pt Arial, Helvetica, sans-serif; margin-top: 0px;">Showing Percentage of Net Assets</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="0" cellpadding="5" width="745">
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Common Stocks - 96.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td/><td style="font-weight: bold;" align="center" valign="bottom">Shares&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Value&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Air Freight &amp; Logistics - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Air Freight &amp; Logistics - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Best, Inc. ADR&#160;</td><td valign="top"/><td align="right" valign="bottom">312,800&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">$3,622,224&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Automobiles - 4.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Automobile Manufacturers - 4.3%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Tesla, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">230,109&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">76,288,037&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Biotechnology - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Biotechnology - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">BeiGene Ltd. ADR  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">38,700&#160;</td><td align="right" valign="bottom">3,572,010&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Zai Lab Ltd. ADR&#160;</td><td valign="top"/><td align="right" valign="bottom">13,300&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">359,233&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">3,931,243&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Chemicals - 0.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Industrial Gases - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">SK Materials Co., Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">12,580&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,109,624&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Specialty Chemicals - 0.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Duk San Neolux Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">239,698&#160;</td><td align="right" valign="bottom">4,705,678&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Soulbrain Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">54,828&#160;</td><td align="right" valign="bottom">3,373,759&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Tokyo Ohka Kogyo Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">68,500&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,505,048&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">10,584,485&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL CHEMICALS&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">12,694,109&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Communications Equipment - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Communications Equipment - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Applied Optoelectronics, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">38,800&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,580,712&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Diversified Consumer Services - 1.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Education Services - 1.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">China Online Education Group sponsored ADR  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">2,563&#160;</td><td align="right" valign="bottom">33,627&#160;</td>
</tr>
<tr>
<td align="left" valign="top">New Oriental Education &amp; Technology Group, Inc. sponsored ADR&#160;</td><td valign="top"/><td align="right" valign="bottom">154,300&#160;</td><td align="right" valign="bottom">12,843,932&#160;</td>
</tr>
<tr>
<td align="left" valign="top">TAL Education Group ADR&#160;</td><td valign="top"/><td align="right" valign="bottom">494,042&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">13,586,155&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">26,463,714&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Diversified Financial Services - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Other Diversified Financial Services - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">GDS Holdings Ltd. ADR&#160;</td><td valign="top"/><td align="right" valign="bottom">239,500&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">3,760,150&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electrical Equipment - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electrical Components &amp; Equipment - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Rockwell Automation, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">19,900&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">3,996,318&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electronic Equipment &amp; Components - 5.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electronic Components - 1.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Genius Electronic Optical Co. Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">131,000&#160;</td><td align="right" valign="bottom">1,475,695&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Largan Precision Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">73,000&#160;</td><td align="right" valign="bottom">13,842,823&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ledlink Optics, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">608,609&#160;</td><td align="right" valign="bottom">947,102&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Lens Technology Co. Ltd. Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">830,737&#160;</td><td align="right" valign="bottom">4,164,390&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sunny Optical Technology Group Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">291,100&#160;</td><td align="right" valign="bottom">4,261,238&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Universal Display Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">18,912&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,770,608&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">27,461,856&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electronic Equipment &amp; Instruments - 3.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Chroma ATE, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">3,026,173&#160;</td><td align="right" valign="bottom">14,760,350&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cognex Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">35,800&#160;</td><td align="right" valign="bottom">4,408,770&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Hexagon AB (B Shares)&#160;</td><td valign="top"/><td align="right" valign="bottom">51,600&#160;</td><td align="right" valign="bottom">2,646,059&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Topcon Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">430,600&#160;</td><td align="right" valign="bottom">9,104,422&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Trimble, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">644,196&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">26,334,732&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">57,254,333&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Technology Distributors - 0.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Dell Technologies, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">85,760&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">7,098,355&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL ELECTRONIC EQUIPMENT &amp; COMPONENTS&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">91,814,544&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Equipment &amp; Supplies - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Supplies - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Hoya Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">45,100&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,450,316&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Technology - 0.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Health Care Technology - 0.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">athenahealth, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">48,994&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">6,265,353&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Hotels, Restaurants &amp; Leisure - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Casinos &amp; Gaming - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sea Ltd. ADR&#160;</td><td valign="top"/><td align="right" valign="bottom">28,700&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">432,796&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet &amp; Direct Marketing Retail - 1.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet &amp; Direct Marketing Retail - 1.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Amazon.com, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">8,500&#160;</td><td align="right" valign="bottom">9,394,880&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cogobuy Group&#160;</td><td valign="top"/><td align="right" valign="bottom">150,000&#160;</td><td align="right" valign="bottom">90,176&#160;</td>
</tr>
<tr>
<td align="left" valign="top">JD.com, Inc. sponsored ADR  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">21,400&#160;</td><td align="right" valign="bottom">802,928&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Netflix, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">85,900&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">16,873,337&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">27,161,321&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet Software &amp; Services - 23.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet Software &amp; Services - 23.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">58.com, Inc. ADR  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">64,981&#160;</td><td align="right" valign="bottom">4,364,774&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Akamai Technologies, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">187,000&#160;</td><td align="right" valign="bottom">9,770,750&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Alibaba Group Holding Ltd. sponsored ADR  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">287,100&#160;</td><td align="right" valign="bottom">53,081,919&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Alphabet, Inc.:&#160;</td><td valign="top"/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Class A (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">66,087&#160;</td><td align="right" valign="bottom">68,270,514&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Class C (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">76,055&#160;</td><td align="right" valign="bottom">77,320,555&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Benefitfocus, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">23,689&#160;</td><td align="right" valign="bottom">649,079&#160;</td>
</tr>
<tr>
<td align="left" valign="top">CoStar Group, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">5,100&#160;</td><td align="right" valign="bottom">1,508,325&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Endurance International Group Holdings, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">457,000&#160;</td><td align="right" valign="bottom">3,747,400&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Envestnet, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">145&#160;</td><td align="right" valign="bottom">7,743&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Facebook, Inc. Class A (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">615,311&#160;</td><td align="right" valign="bottom">110,792,899&#160;</td>
</tr>
<tr>
<td align="left" valign="top">GoDaddy, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">90,200&#160;</td><td align="right" valign="bottom">4,212,340&#160;</td>
</tr>
<tr>
<td align="left" valign="top">LogMeIn, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">142,333&#160;</td><td align="right" valign="bottom">17,229,410&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NetEase, Inc. ADR&#160;</td><td valign="top"/><td align="right" valign="bottom">56,900&#160;</td><td align="right" valign="bottom">16,041,248&#160;</td>
</tr>
<tr>
<td align="left" valign="top">New Relic, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">89,000&#160;</td><td align="right" valign="bottom">4,568,370&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Nutanix, Inc. Class B (c)&#160;</td><td valign="top"/><td align="right" valign="bottom">39,963&#160;</td><td align="right" valign="bottom">1,138,946&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Pandora Media, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">93,000&#160;</td><td align="right" valign="bottom">679,830&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Shopify, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,600&#160;</td><td align="right" valign="bottom">159,184&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Shopify, Inc. Class A (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">22,800&#160;</td><td align="right" valign="bottom">2,266,745&#160;</td>
</tr>
<tr>
<td align="left" valign="top">SMS Co., Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">312,400&#160;</td><td align="right" valign="bottom">9,410,873&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Tencent Holdings Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">309,600&#160;</td><td align="right" valign="bottom">13,915,005&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Twilio, Inc. Class A (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">4,000&#160;</td><td align="right" valign="bottom">127,800&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Xunlei Ltd. sponsored ADR  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">420,444&#160;</td><td align="right" valign="bottom">3,897,516&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Yandex NV Series A (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">154,800&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">5,236,884&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">408,398,109&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">IT Services - 6.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Data Processing &amp; Outsourced Services - 3.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity National Information Services, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">18,295&#160;</td><td align="right" valign="bottom">1,697,044&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fiserv, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">26,400&#160;</td><td align="right" valign="bottom">3,416,952&#160;</td>
</tr>
<tr>
<td align="left" valign="top">FleetCor Technologies, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">78,300&#160;</td><td align="right" valign="bottom">12,940,641&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Global Payments, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">68,300&#160;</td><td align="right" valign="bottom">7,099,785&#160;</td>
</tr>
<tr>
<td align="left" valign="top">PayPal Holdings, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">386,000&#160;</td><td align="right" valign="bottom">28,008,160&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Total System Services, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">38,153&#160;</td><td align="right" valign="bottom">2,748,924&#160;</td>
</tr>
<tr>
<td align="left" valign="top">WEX, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">50,600&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">6,253,654&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">62,165,160&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">IT Consulting &amp; Other Services - 2.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cognizant Technology Solutions Corp. Class A&#160;</td><td valign="top"/><td align="right" valign="bottom">451,294&#160;</td><td align="right" valign="bottom">34,149,417&#160;</td>
</tr>
<tr>
<td align="left" valign="top">CSRA, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">38,400&#160;</td><td align="right" valign="bottom">1,228,416&#160;</td>
</tr>
<tr>
<td align="left" valign="top">DXC Technology Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">86,400&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">7,907,328&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">43,285,161&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL IT SERVICES&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">105,450,321&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Life Sciences Tools &amp; Services - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Life Sciences Tools &amp; Services - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">JHL Biotech, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">387,462&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">636,513&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Machinery - 1.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Industrial Machinery - 1.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">HIWIN Technologies Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">453,900&#160;</td><td align="right" valign="bottom">4,548,338&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Minebea Mitsumi, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,266,200&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">23,213,391&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">27,761,729&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Media - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Advertising - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">iCar Asia Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,156,712&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">177,058&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Publishing - 0.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">China Literature Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,503&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">10,596&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL MEDIA&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">187,654&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Professional Services - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Human Resource &amp; Employment Services - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">WageWorks, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">28,744&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,832,430&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Real Estate Management &amp; Development - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Real Estate Services - 0.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Relo Holdings Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">75,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,856,816&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Semiconductors &amp; Semiconductor Equipment - 21.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Semiconductor Equipment - 6.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ASM Pacific Technology Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,813,600&#160;</td><td align="right" valign="bottom">26,385,469&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ferrotec Holdings Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">126,800&#160;</td><td align="right" valign="bottom">2,606,616&#160;</td>
</tr>
<tr>
<td align="left" valign="top">GlobalWafers Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">2,032,400&#160;</td><td align="right" valign="bottom">23,501,606&#160;</td>
</tr>
<tr>
<td align="left" valign="top">KLA-Tencor Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">79,400&#160;</td><td align="right" valign="bottom">8,645,866&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Lam Research Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">138,500&#160;</td><td align="right" valign="bottom">28,886,945&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Screen Holdings Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">62,100&#160;</td><td align="right" valign="bottom">4,867,313&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Siltronic AG  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">39,600&#160;</td><td align="right" valign="bottom">5,867,489&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sino-American Silicon Products, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">4,118,000&#160;</td><td align="right" valign="bottom">11,477,603&#160;</td>
</tr>
<tr>
<td align="left" valign="top">SolarEdge Technologies, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">40,000&#160;</td><td align="right" valign="bottom">1,314,000&#160;</td>
</tr>
<tr>
<td align="left" valign="top">SunEdison, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">500&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">10&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">113,552,917&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Semiconductors - 14.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Acacia Communications, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">28,600&#160;</td><td align="right" valign="bottom">1,210,066&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Advanced Micro Devices, Inc.  (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,231,600&#160;</td><td align="right" valign="bottom">13,529,126&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Advanced Semiconductor Engineering, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">183,000&#160;</td><td align="right" valign="bottom">221,400&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ams AG&#160;</td><td valign="top"/><td align="right" valign="bottom">288,874&#160;</td><td align="right" valign="bottom">26,334,978&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ASPEED Tech, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">116,282&#160;</td><td align="right" valign="bottom">2,689,248&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Broadcom Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">82,200&#160;</td><td align="right" valign="bottom">21,693,402&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cavium, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">25,900&#160;</td><td align="right" valign="bottom">1,786,841&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ChipMOS TECHNOLOGIES, Inc. sponsored ADR  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">125,152&#160;</td><td align="right" valign="bottom">2,503,040&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cirrus Logic, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">15,814&#160;</td><td align="right" valign="bottom">885,584&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cree, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">333,600&#160;</td><td align="right" valign="bottom">11,909,520&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Global Unichip Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">261,000&#160;</td><td align="right" valign="bottom">2,598,049&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Himax Technologies, Inc. sponsored ADR  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,401,404&#160;</td><td align="right" valign="bottom">14,294,321&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Inphi Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">102,517&#160;</td><td align="right" valign="bottom">4,201,147&#160;</td>
</tr>
<tr>
<td align="left" valign="top">M/A-COM Technology Solutions Holdings, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">78,900&#160;</td><td align="right" valign="bottom">3,225,432&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Marvell Technology Group Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">386,361&#160;</td><td align="right" valign="bottom">7,136,088&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Mellanox Technologies Ltd.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">222,100&#160;</td><td align="right" valign="bottom">10,383,175&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Micron Technology, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">688,250&#160;</td><td align="right" valign="bottom">30,496,358&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Monolithic Power Systems, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">59,601&#160;</td><td align="right" valign="bottom">7,251,654&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Nanya Technology Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">12,034,000&#160;</td><td align="right" valign="bottom">32,662,459&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NVIDIA Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">203,750&#160;</td><td align="right" valign="bottom">42,137,538&#160;</td>
</tr>
<tr>
<td align="left" valign="top">ON Semiconductor Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">148,600&#160;</td><td align="right" valign="bottom">3,168,152&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Qualcomm, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">62,150&#160;</td><td align="right" valign="bottom">3,170,272&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Renesas Electronics Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">106,800&#160;</td><td align="right" valign="bottom">1,380,827&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Semtech Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">110,998&#160;</td><td align="right" valign="bottom">4,556,468&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Silergy Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">72,000&#160;</td><td align="right" valign="bottom">1,555,246&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Silicon Laboratories, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">21,100&#160;</td><td align="right" valign="bottom">2,002,390&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Silicon Motion Technology Corp. sponsored ADR  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">81,388&#160;</td><td align="right" valign="bottom">3,940,807&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Win Semiconductors Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">247,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">2,020,224&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">258,943,812&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL SEMICONDUCTORS &amp; SEMICONDUCTOR EQUIPMENT&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">372,496,729&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Software - 20.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Application Software - 9.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Adobe Systems, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">74,616&#160;</td><td align="right" valign="bottom">13,069,739&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Aspen Technology, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">300&#160;</td><td align="right" valign="bottom">19,356&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Autodesk, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">487,000&#160;</td><td align="right" valign="bottom">60,855,520&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Callidus Software, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">177,059&#160;</td><td align="right" valign="bottom">4,488,446&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Citrix Systems, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">74,000&#160;</td><td align="right" valign="bottom">6,113,140&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ellie Mae, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">90,900&#160;</td><td align="right" valign="bottom">8,176,455&#160;</td>
</tr>
<tr>
<td align="left" valign="top">HubSpot, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">6,900&#160;</td><td align="right" valign="bottom">597,195&#160;</td>
</tr>
<tr>
<td align="left" valign="top">iFlytek Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">237,677&#160;</td><td align="right" valign="bottom">1,920,072&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Parametric Technology Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">262,400&#160;</td><td align="right" valign="bottom">17,436,480&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Paylocity Holding Corp.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">17,900&#160;</td><td align="right" valign="bottom">956,039&#160;</td>
</tr>
<tr>
<td align="left" valign="top">RealPage, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">5,800&#160;</td><td align="right" valign="bottom">251,140&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Salesforce.com, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">236,919&#160;</td><td align="right" valign="bottom">24,246,290&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Snap, Inc. Class A (a)(b)&#160;</td><td valign="top"/><td align="right" valign="bottom">262,700&#160;</td><td align="right" valign="bottom">4,029,818&#160;</td>
</tr>
<tr>
<td align="left" valign="top">SS&amp;C Technologies Holdings, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">79,200&#160;</td><td align="right" valign="bottom">3,183,840&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Ultimate Software Group, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">75,476&#160;</td><td align="right" valign="bottom">15,290,683&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Workday, Inc. Class A (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">14,700&#160;</td><td align="right" valign="bottom">1,631,553&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Zendesk, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">201,400&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">6,243,400&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">168,509,166&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Home Entertainment Software - 4.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Activision Blizzard, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">353,070&#160;</td><td align="right" valign="bottom">23,122,554&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Electronic Arts, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">201,400&#160;</td><td align="right" valign="bottom">24,087,440&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Nintendo Co. Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">54,300&#160;</td><td align="right" valign="bottom">21,066,326&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Nintendo Co. Ltd. ADR&#160;</td><td valign="top"/><td align="right" valign="bottom">92,500&#160;</td><td align="right" valign="bottom">4,500,125&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Take-Two Interactive Software, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">98,400&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">10,887,960&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">83,664,405&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Systems Software - 5.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Microsoft Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">986,500&#160;</td><td align="right" valign="bottom">82,057,070&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Red Hat, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">36,200&#160;</td><td align="right" valign="bottom">4,374,046&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Tableau Software, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">182,700&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">14,815,143&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">101,246,259&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL SOFTWARE&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">353,419,830&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Technology Hardware, Storage &amp; Peripherals - 10.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Technology Hardware, Storage &amp; Peripherals - 10.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Apple, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">1,034,429&#160;</td><td align="right" valign="bottom">174,859,875&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Primax Electronics Ltd.&#160;</td><td valign="top"/><td align="right" valign="bottom">645,000&#160;</td><td align="right" valign="bottom">1,673,601&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Quanta Computer, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">69,000&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">162,552&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">176,696,028&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL COMMON STOCKS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $1,110,940,736)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">1,709,196,996&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Convertible Preferred Stocks - 1.7%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet &amp; Direct Marketing Retail - 1.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet &amp; Direct Marketing Retail - 1.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">China Internet Plus Holdings Ltd.:&#160;</td><td valign="top"/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Series A-11  (a)(d)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,516,912&#160;</td><td align="right" valign="bottom">8,478,112&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Series B  (a)(d)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">2,042,487&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">11,415,582&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">19,893,694&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet Software &amp; Services - 0.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Internet Software &amp; Services - 0.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Uber Technologies, Inc. Series D, 8.00% (a)(d)(e)&#160;</td><td valign="top"/><td align="right" valign="bottom">232,064&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">10,264,191&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL CONVERTIBLE PREFERRED STOCKS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $16,280,181)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">30,157,885&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Money Market Funds - 7.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund, 1.10% (f)&#160;</td><td valign="top"/><td align="right" valign="bottom">24,319,184&#160;</td><td align="right" valign="bottom">24,324,048&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund 1.11% (f)(g)&#160;</td><td valign="top"/><td align="right" valign="bottom">109,046,058&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">109,056,963&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL MONEY MARKET FUNDS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $133,380,010)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">133,381,011&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL INVESTMENT IN SECURITIES - 106.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">(Cost $1,260,600,927)&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td style="font-weight: bold;" align="right" valign="top">1,872,735,892&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET OTHER ASSETS (LIABILITIES) - (6.0)%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">(106,044,035)&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET ASSETS - 100%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: double 3px black; font-weight: bold;">$1,766,691,857&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 12pt Arial, Helvetica, sans-serif;">Legend</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(a)&#160;Non-income producing</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(b)&#160;Security or a portion of the security is on loan at period end.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(c)&#160;Security exempt from registration under Rule 144A of the Securities Act of 1933.  These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $1,138,946 or 0.1% of net assets.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(d)&#160;Restricted securities - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues).  At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $30,157,885 or 1.7% of net assets.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(e)&#160;Level 3 security</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(f)&#160;Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(g)&#160;Investment made with cash collateral received from securities on loan.</p>
<br/>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Additional information on each restricted holding is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Security&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Acquisition Date&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Acquisition Cost&#160;</td>
</tr>
<tr>
<td align="left" valign="top">China Internet Plus Holdings Ltd. Series A-11&#160;</td><td align="right" valign="bottom">1/26/15&#160;</td><td align="right" valign="bottom">$4,794,731&#160;</td>
</tr>
<tr>
<td align="left" valign="top">China Internet Plus Holdings Ltd. Series B&#160;</td><td align="right" valign="bottom">12/11/15&#160;</td><td align="right" valign="bottom">$7,885,430&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Uber Technologies, Inc. Series D, 8.00%&#160;</td><td align="right" valign="bottom">6/6/14&#160;</td><td align="right" valign="bottom">$3,600,020&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Affiliated Central Funds</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Fund&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Income earned&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund&#160;</td><td align="right" valign="bottom">$67,194&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">301,041&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Total&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$368,235&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investment Valuation</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">The following is a summary of the inputs used, as of October 31, 2017, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. Additional information on valuation inputs, and their aggregation into the levels used below, is provided later in this section.</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td style="font-weight: bold;" align="center" valign="bottom" colspan="4">Valuation Inputs at Reporting Date:&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Description&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Total&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 1&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 2&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 3&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top"><u>Investments in Securities:</u>&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Common Stocks&#160;</td><td align="right" valign="bottom">$1,709,196,996&#160;</td><td align="right" valign="bottom">$1,616,588,047&#160;</td><td align="right" valign="bottom">$92,608,949&#160;</td><td align="right" valign="bottom">$--&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Convertible Preferred Stocks&#160;</td><td align="right" valign="bottom">30,157,885&#160;</td><td align="right" valign="bottom">--&#160;</td><td align="right" valign="bottom">--&#160;</td><td align="right" valign="bottom">30,157,885&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Money Market Funds&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">133,381,011&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">133,381,011&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td>
</tr>
<tr>
<td style="font-weight: bold" valign="top">Total Investments in Securities:&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$1,872,735,892&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$1,749,969,058&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$92,608,949&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$30,157,885&#160;</td>
</tr>
</table>
<br/>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">The following is a summary of transfers between Level 1 and Level 2 for the period ended October 31, 2017. Transfers are assumed to have occurred at the beginning of the period, and are primarily attributable to the valuation techniques used for foreign equity securities, as discussed at the end of this section:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Transfers&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Total&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Level 1 to Level 2&#160;</td><td align="right" valign="bottom">$41,307,432&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Level 2 to Level 1&#160;</td><td align="right" valign="bottom">$0&#160;</td>
</tr>
</table>
<br/>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">The following is a reconciliation of Investments in Securities for which Level 3 inputs were used in determining value:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font-weight:bold;">
<td align="left" valign="top">Investments in Securities:&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="border-bottom: solid 1px black;">Convertible Preferred Stocks&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Beginning Balance&#160;</td><td align="right" valign="bottom">$31,464,476&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Total Realized Gain (Loss)&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Total Unrealized Gain (Loss)&#160;</td><td align="right" valign="bottom">(1,306,591)&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Cost of Purchases&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Proceeds of Sales&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Amortization/Accretion&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Transfers in to Level 3&#160;</td><td align="right" valign="bottom">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Transfers out of Level 3&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">Ending Balance&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$30,157,885&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">The change in unrealized gain (loss) for the period attributable to Level 3 securities held at October 31, 2017&#160;</td><td align="right" valign="bottom">$(1,306,591)&#160;</td>
</tr>
</table>
<br/>
<p style="font: italic 10pt Arial, Helvetica, sans-serif;">The information used in the above reconciliation represents fiscal year to date activity for any Investments in Securities identified as using Level 3 inputs at either the beginning or the end of the current fiscal period. Transfers in or out of Level 3 represent the beginning value of any Security or Instrument where a change in the pricing level occurred from the beginning to the end of the period. The cost of purchases and the proceeds of sales may include securities received or delivered through corporate actions or exchanges.</p>
<p>Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund&#146;s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:</p>
<p>Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. Utilizing these techniques may result in transfers between Level 1 and Level 2. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy. Equity securities, including restricted securities, for which observable inputs are not available, are valued using alternate valuation approaches, including the market approach and the income approach and are categorized as Level 3 in the hierarchy. The market approach generally consists of using comparable market transactions while the income approach generally consists of using the net present value of estimated future cash flows, adjusted as appropriate for liquidity, credit, market and/or other risk factors.</p>
<p>Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.</p>
<p>The following provides information on Level 3 securities held by the fund that were valued at period end based on unobservable inputs. These amounts exclude valuations provided by a broker.</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Asset Type&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Fair Value&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Valuation Technique (s)&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Unobservable Input&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Amount or Range / Weighted Average&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Impact to Valuation from an Increase in Input(a)&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Equities&#160;</td><td align="right" valign="bottom">$30,157,885&#160;</td><td align="right" valign="bottom">Market approach&#160;</td><td align="right" valign="bottom">Transaction price&#160;</td><td align="right" valign="bottom">$5.59&#160;</td><td align="right" valign="bottom">Increase&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">Market comparable&#160;</td><td align="right" valign="bottom">Enterprise value/Sales multiple (EV/S)&#160;</td><td align="right" valign="bottom">4.5&#160;</td><td align="right" valign="bottom">Increase&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">Discount rate&#160;</td><td align="right" valign="bottom">10.0%&#160;</td><td align="right" valign="bottom">Decrease&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">Recovery value&#160;</td><td align="right" valign="bottom">Recovery value&#160;</td><td align="right" valign="bottom">0.0%&#160;</td><td align="right" valign="bottom">Increase&#160;</td>
</tr>
</table>
<br/>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(a)&#160;<i>Represents the expected directional change in the fair value of the Level 3 investments that would result from an increase in the corresponding input. A decrease to the unobservable input would have the opposite effect. Significant changes in these inputs could result in significantly higher or lower fair value measurements.</i>
</p>
<br/>
<p>For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.</p>
<br/>
<br/>
<br/>
<br/>
<p style="font-style: italic;">
</p><p style="font-style: italic;">The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.</p>

<p style="font-style: italic;">
</p><p style="font-style: italic;">Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.</p>

<hr size="2" noshade="noshade"/>
</div>
<div style="font: normal 11pt Arial, Helvetica, sans-serif; width: 780px">
<!-- Automatically produced using the ProofPlus Content Management System -->
<p style="font: bold 18pt Arial, Helvetica, sans-serif; margin-bottom: 0px;" align="center">Quarterly Holdings Report<br clear="all"/>for</p>
<p style="font: bold 20pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">Fidelity Advisor&#174; Utilities Fund</p>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-top: 0px;" align="center">October 31, 2017</p>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>AFUG-QTLY-1217<br/>1.809068.114<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<a name="">
<p style="font: bold 16pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investments October 31, 2017 (Unaudited)</p>
</a>
<p style="font: normal 11pt Arial, Helvetica, sans-serif; margin-top: 0px;">Showing Percentage of Net Assets</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="0" cellpadding="5" width="745">
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Common Stocks - 97.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td/><td style="font-weight: bold;" align="center" valign="bottom">Shares&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Value&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electric Utilities - 54.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Electric Utilities - 54.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Exelon Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">762,691&#160;</td><td align="right" valign="bottom">$30,667,805&#160;</td>
</tr>
<tr>
<td align="left" valign="top">FirstEnergy Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">303,233&#160;</td><td align="right" valign="bottom">9,991,527&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Great Plains Energy, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">473,900&#160;</td><td align="right" valign="bottom">15,558,137&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NextEra Energy, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">365,950&#160;</td><td align="right" valign="bottom">56,747,866&#160;</td>
</tr>
<tr>
<td align="left" valign="top">OGE Energy Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">160,123&#160;</td><td align="right" valign="bottom">5,898,931&#160;</td>
</tr>
<tr>
<td align="left" valign="top">PG&amp;E Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">371,405&#160;</td><td align="right" valign="bottom">21,456,067&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Southern Co.&#160;</td><td valign="top"/><td align="right" valign="bottom">287,500&#160;</td><td align="right" valign="bottom">15,007,500&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Vistra Energy Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">503,888&#160;</td><td align="right" valign="bottom">9,795,583&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Westar Energy, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">129,151&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">6,906,995&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">172,030,411&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Equity Real Estate Investment Trusts (REITs) - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Specialized REITs - 0.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">InfraReit, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">29,202&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">654,125&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Independent Power and Renewable Electricity Producers - 9.0%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Independent Power Producers &amp; Energy Traders - 6.1%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NRG Energy, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">535,972&#160;</td><td align="right" valign="bottom">13,399,300&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NRG Yield, Inc. Class C&#160;</td><td valign="top"/><td align="right" valign="bottom">74,502&#160;</td><td align="right" valign="bottom">1,385,737&#160;</td>
</tr>
<tr>
<td align="left" valign="top">The AES Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">419,020&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,454,183&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">19,239,220&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Renewable Electricity - 2.9%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">NextEra Energy Partners LP&#160;</td><td valign="top"/><td align="right" valign="bottom">237,830&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">9,356,232&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">TOTAL INDEPENDENT POWER AND RENEWABLE ELECTRICITY PRODUCERS&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">28,595,452&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Multi-Utilities - 31.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Multi-Utilities - 31.5%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Avangrid, Inc.  (a)&#160;</td><td valign="top"/><td align="right" valign="bottom">305,630&#160;</td><td align="right" valign="bottom">15,810,240&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Black Hills Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">67,903&#160;</td><td align="right" valign="bottom">4,431,350&#160;</td>
</tr>
<tr>
<td align="left" valign="top">CenterPoint Energy, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">374,513&#160;</td><td align="right" valign="bottom">11,078,095&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Dominion Resources, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">142,294&#160;</td><td align="right" valign="bottom">11,545,735&#160;</td>
</tr>
<tr>
<td align="left" valign="top">E.ON AG&#160;</td><td valign="top"/><td align="right" valign="bottom">145,978&#160;</td><td align="right" valign="bottom">1,729,028&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Public Service Enterprise Group, Inc.&#160;</td><td valign="top"/><td align="right" valign="bottom">194,538&#160;</td><td align="right" valign="bottom">9,571,270&#160;</td>
</tr>
<tr>
<td align="left" valign="top">SCANA Corp.&#160;</td><td valign="top"/><td align="right" valign="bottom">146,548&#160;</td><td align="right" valign="bottom">6,322,081&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Sempra Energy&#160;</td><td valign="top"/><td align="right" valign="bottom">336,709&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">39,563,308&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">100,051,107&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Oil, Gas &amp; Consumable Fuels - 2.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">Oil &amp; Gas Storage &amp; Transport - 2.4%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cheniere Energy Partners LP Holdings LLC&#160;</td><td valign="top"/><td align="right" valign="bottom">134,662&#160;</td><td align="right" valign="bottom">3,371,936&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Cheniere Energy, Inc.  (b)&#160;</td><td valign="top"/><td align="right" valign="bottom">91,766&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">4,289,143&#160;</td>
</tr>
<tr>
<td align="left" valign="top">&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black;">7,661,079&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL COMMON STOCKS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $242,543,174)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">308,992,174&#160;</td>
</tr>
<tr>
<td/>
</tr>
<tr style="font-weight:bold; color: #ffffff; background-color: #000000;">
<td align="left" valign="top">Money Market Funds - 0.6%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund, 1.10% (c)&#160;</td><td valign="top"/><td align="right" valign="bottom">725,559&#160;</td><td align="right" valign="bottom">725,705&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund 1.11% (c)(d)&#160;</td><td valign="top"/><td align="right" valign="bottom">1,128,287&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,128,400&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL MONEY MARKET FUNDS&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td style="padding-left:20px; text-indent:-10px; " align="left" valign="top">(Cost $1,854,105)&#160;</td><td/><td align="right" valign="top">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">1,854,105&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">TOTAL INVESTMENT IN SECURITIES - 97.8%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top" style="padding-left:20px; text-indent:-10px; ">(Cost $244,397,279)&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td style="font-weight: bold;" align="right" valign="top">310,846,279&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET OTHER ASSETS (LIABILITIES) - 2.2%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: solid 1px black; font-weight: bold;">7,001,206&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top">NET ASSETS - 100%&#160;</td><td/><td align="right" valign="bottom">&#160;</td><td align="right" valign="top" style="border-bottom: double 3px black; font-weight: bold;">$317,847,485&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 12pt Arial, Helvetica, sans-serif;">Legend</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(a)&#160;Security or a portion of the security is on loan at period end.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(b)&#160;Non-income producing</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(c)&#160;Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.</p>
<p style="font: 10pt Arial, Helvetica, sans-serif;">&#160;(d)&#160;Investment made with cash collateral received from securities on loan.</p>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Affiliated Central Funds</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Fund&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Income earned&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Cash Central Fund&#160;</td><td align="right" valign="bottom">$7,934&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Fidelity Securities Lending Cash Central Fund&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">20&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Total&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$7,954&#160;</td>
</tr>
</table>
<br/>
<p style="font: bold 14pt Arial, Helvetica, sans-serif; margin-bottom: 0px;">Investment Valuation</p>
<p style="font: normal 10pt Arial, Helvetica, sans-serif;">The following is a summary of the inputs used, as of October 31, 2017, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. Additional information on valuation inputs, and their aggregation into the levels used below, is provided later in this section.</p>
<table style="font: 9pt Arial, Helvetica, sans-serif;" border="0" cellspacing="7" cellpadding="0" width="745">
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">&#160;</td><td style="font-weight: bold;" align="center" valign="bottom" colspan="4">Valuation Inputs at Reporting Date:&#160;</td>
</tr>
<tr style="font:bold; border-bottom: solid 1px black;">
<td style="font-weight: bold;" align="left" valign="bottom">Description&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Total&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 1&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 2&#160;</td><td style="font-weight: bold;" align="center" valign="bottom">Level 3&#160;</td>
</tr>
<tr style="font-weight:bold;">
<td align="left" valign="top"><u>Investments in Securities:</u>&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td><td align="right" valign="bottom">&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Common Stocks&#160;</td><td align="right" valign="bottom">$308,992,174&#160;</td><td align="right" valign="bottom">$307,263,146&#160;</td><td align="right" valign="bottom">$1,729,028&#160;</td><td align="right" valign="bottom">$--&#160;</td>
</tr>
<tr>
<td align="left" valign="top">Money Market Funds&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,854,105&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">1,854,105&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td><td align="right" valign="bottom" style="border-bottom: solid 1px black;">--&#160;</td>
</tr>
<tr>
<td style="font-weight: bold" valign="top">Total Investments in Securities:&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$310,846,279&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$309,117,251&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$1,729,028&#160;</td><td align="right" valign="bottom" style="border-bottom: double 3px black;">$--&#160;</td>
</tr>
</table>
<br/>
<p>Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund&#146;s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:</p>
<p>Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. Utilizing these techniques may result in transfers between Level 1 and Level 2. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.</p>
<p>Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.</p>
<p>For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.</p>
<br/>
<br/>
<br/>
<br/>
<p style="font-style: italic;">
</p><p style="font-style: italic;">The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.</p>

<p style="font-style: italic;">
</p><p style="font-style: italic;">Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.</p>

<hr size="2" noshade="noshade"/>
</div>
<div style="width:576px"><p style="margin-top:0px; margin-bottom:-2px; width:96px; font-size:12pt; float:left">Item 2.</p>
<p style="margin:0px; text-indent:-2px; font-size:12pt"><u>Controls and Procedures</u></p>
<p style="margin:0px; clear:left"><br/></p>
<p style="margin:0px; font-size:12pt">(a)(i) &#160;The President and Treasurer and the Chief Financial Officer have concluded that the Fidelity Advisor Series VII<font style="font-family:Arial Unicode MS,Times New Roman">&#8217;</font>s (the <font style="font-family:Arial Unicode MS,Times New Roman">&#8220;</font>Trust<font style="font-family:Arial Unicode MS,Times New Roman">&#8221;</font>) disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act) provide reasonable assurances that material information relating to the Trust is made known to them by the appropriate persons, based on their evaluation of these controls and procedures as of a date within 90 days of the filing date of this report.</p>
<p style="margin:0px"><br/></p>
<p style="margin:0px; font-size:12pt">(a)(ii) &#160;There was no change in the Trust<font style="font-family:Arial Unicode MS,Times New Roman">&#8217;</font>s internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act) that occurred during the Trust<font style="font-family:Arial Unicode MS,Times New Roman">&#8217;</font>s last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Trust<font style="font-family:Arial Unicode MS,Times New Roman">&#8217;</font>s internal control over financial reporting.</p>
<p style="margin:0px"><br/></p>
<p style="margin-top:0px; margin-bottom:-2px; width:96px; font-size:12pt; float:left">Item 3.</p>
<p style="margin:0px; text-indent:-2px; font-size:12pt"><u>Exhibits</u></p>
<p style="margin:0px; clear:left"><br/></p>
<table style="margin-top:0px; font-size:10pt" cellpadding="0" cellspacing="0"><tr height="0" style="font-size:0"><td width="499.2"/></tr>
<tr><td style="margin-top:0px" valign="top" width="499.2" height="29"><p style="margin:0px; font-size:12pt">Certification pursuant to Rule 30a-2(a) under the Investment Company Act of 1940 (17 CFR 270.30a-2(a)) is filed and attached hereto as Exhibit 99.CERT.</p>
</td></tr>
</table>
<p style="margin:0px" align="center"><br/></p>
<p style="margin:0px" align="center"><br/>
<br/></p>
<p style="margin:0px; font-size:12pt; page-break-before:always" align="center">SIGNATURES</p>
<p style="margin:0px"><br/></p>
<p style="margin:0px; font-size:12pt">Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</p>
<p style="margin:0px"><br/></p>
<p style="margin:0px; font-size:12pt">Fidelity Advisor Series VII</p>
<p style="margin:0px"><br/></p>
<p style="margin:0px"><br/></p>
<table style="margin-top:0px; font-size:10pt" cellpadding="0" cellspacing="0"><tr height="0" style="font-size:0"><td width="147.6"/><td width="219.6"/></tr>
<tr><td style="margin-top:0px" valign="top" width="147.6"><p style="margin:0px; font-size:12pt">By:</p>
</td><td style="margin-top:0px" valign="top" width="219.6"><p style="margin:0px; font-size:12pt"><u>/s/Adrien E. Deberghes</u></p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="147.6"><p style="margin:0px"><br/></p>
</td><td style="margin-top:0px" valign="top" width="219.6"><p style="margin:0px; font-size:12pt">Adrien E. Deberghes</p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="147.6"><p style="margin:0px"><br/></p>
</td><td style="margin-top:0px" valign="top" width="219.6"><p style="margin:0px; font-size:12pt">President and Treasurer</p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="147.6"><p style="margin:0px"><br/></p>
</td><td style="margin-top:0px" valign="top" width="219.6"><p style="margin:0px"><br/></p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="147.6"><p style="margin:0px; font-size:12pt">Date:</p>
</td><td style="margin-top:0px" valign="top" width="219.6"><p style="margin:0px; font-size:12pt">December 28, 2017</p>
</td></tr>
</table>
<p style="margin:0px"><br/></p>
<p style="margin:0px; font-size:12pt">Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</p>
<p style="margin:0px"><br/></p>
<p style="margin:0px"><br/></p>
<table style="margin-top:0px; font-size:10pt" cellpadding="0" cellspacing="0"><tr height="0" style="font-size:0"><td width="151.2"/><td width="216"/></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px; font-size:12pt">By:</p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px; font-size:12pt"><u>/s/Adrien E. Deberghes</u></p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px"><br/></p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px; font-size:12pt">Adrien E. Deberghes</p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px"><br/></p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px; font-size:12pt">President and Treasurer</p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px"><br/></p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px"><br/></p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px; font-size:12pt">Date:</p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px; font-size:12pt">December 28, 2017</p>
</td></tr>
</table>
<p style="margin:0px"><br/></p>
<p style="margin:0px"><br/></p>
<table style="margin-top:0px; font-size:10pt" cellpadding="0" cellspacing="0"><tr height="0" style="font-size:0"><td width="151.2"/><td width="216"/></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px; font-size:12pt">By:</p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px; font-size:12pt"><u>/s/Howard J. Galligan III</u></p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px"><br/></p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px; font-size:12pt">Howard J. Galligan III</p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px"><br/></p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px; font-size:12pt">Chief Financial Officer</p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px"><br/></p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px"><br/></p>
</td></tr>
<tr><td style="margin-top:0px" valign="top" width="151.2"><p style="margin:0px; font-size:12pt">Date:</p>
</td><td style="margin-top:0px" valign="top" width="216"><p style="margin:0px; font-size:12pt">December 28, 2017</p>
</td></tr>
</table>
<p style="margin:0px; font-size:12pt">&#160;</p>
<p style="margin:0px"><br/></p>
<p style="margin:0px"><br/></p>
<p style="margin:0px"><br/>
<br/></p>
</div>


</text>
</description></filename></sequence></type></document>
</body>